{"parse":{"title":"5-oxo-eicosatetraenoic acid","pageid":47891463,"revid":844577417,"text":{"*":"<div class=\"mw-parser-output\"><table class=\"infobox bordered\" style=\"border-collapse:collapse; width:22em; text-align:left;&#32;;\">\n<caption style=\"text-align:center;\">5-oxo-eicosatetraenoic acid\n</caption>\n<tbody><tr>\n<td colspan=\"2\" style=\"text-align:center; padding:2px;\"><a href=\"/wiki/File:5-oxo-ETE.svg\" class=\"image\"><img alt=\"5-oxo-ETE.svg\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/2/2a/5-oxo-ETE.svg/220px-5-oxo-ETE.svg.png\" width=\"220\" height=\"81\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/2/2a/5-oxo-ETE.svg/330px-5-oxo-ETE.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/2/2a/5-oxo-ETE.svg/440px-5-oxo-ETE.svg.png 2x\" data-file-width=\"512\" data-file-height=\"188\" /></a>\n</td></tr>\n<tr>\n<th colspan=\"2\" style=\"background: #f8eaba; text-align: center;\">Names\n</th></tr>\n\n<tr>\n<td colspan=\"2\" style=\"text-align:left;\"><a href=\"/wiki/Chemical_nomenclature\" title=\"Chemical nomenclature\">IUPAC name</a>\n<div style=\"max-width:22em; word-wrap:break-word; padding-left:1.7em;\">5-oxo-6E,8Z,11Z,14Z-eicosatetraenoate</div>\n</td></tr>\n\n\n<tr>\n<td colspan=\"2\" style=\"text-align:left;\">Other names\n<div style=\"max-width:22em; word-wrap:break-word; padding-left:1.7em;\">5-oxo-ETE, 5-oxoETE, 5-KETE</div>\n</td></tr>\n<tr>\n<th colspan=\"2\" style=\"background: #f8eaba; text-align: center;\">Identifiers\n</th></tr>\n\n<tr>\n<td><div style=\"padding:0.1em 0;line-height:1.2em;\"><a href=\"/wiki/CAS_Registry_Number\" title=\"CAS Registry Number\">CAS Number</a></div>\n</td>\n<td><div class=\"plainlist\"><ul><li><span title=\"www.commonchemistry.org\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.commonchemistry.org/ChemicalDetail.aspx?ref=106154-18-1\">106154-18-1</a></span></li></ul></div>\n</td></tr>\n<tr>\n<td><div style=\"padding:0.1em 0;line-height:1.2em;\">3D model (<a href=\"/wiki/JSmol\" class=\"mw-redirect\" title=\"JSmol\">JSmol</a>)</div>\n</td>\n<td><div class=\"plainlist\"><ul><li><span title=\"chemapps.stolaf.edu (3D interactive model)\"><a rel=\"nofollow\" class=\"external text\" href=\"https://chemapps.stolaf.edu/jmol/jmol.php?model=CCCCC%5CC%3DC%2FC%5CC%3DC%2FC%5CC%3DC%2FC%3DC%2FC%28%3DO%29CCCC%28O%29%3DO\">Interactive image</a></span></li></ul></div>\n</td></tr>\n\n\n\n<tr>\n<td><a href=\"/wiki/ChEBI\" title=\"ChEBI\">ChEBI</a>\n</td>\n<td><div class=\"plainlist\"><ul><li><span title=\"www.ebi.ac.uk\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=52449\">CHEBI:52449</a></span></li></ul></div>\n</td></tr>\n<tr>\n<td><a href=\"/wiki/ChEMBL\" title=\"ChEMBL\">ChEMBL</a>\n</td>\n<td><div class=\"plainlist\"><ul><li><span title=\"www.ebi.ac.uk\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL18028\">ChEMBL18028</a></span></li></ul></div>\n</td></tr>\n<tr>\n<td><a href=\"/wiki/ChemSpider\" title=\"ChemSpider\">ChemSpider</a>\n</td>\n<td><div class=\"plainlist\"><ul><li><span title=\"www.chemspider.com\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.chemspider.com/Chemical-Structure.4446283.html\">4446283</a></span></li></ul></div>\n</td></tr>\n\n\n\n\n\n\n<tr>\n<td><a href=\"/wiki/KEGG\" title=\"KEGG\">KEGG</a>\n</td>\n<td><div class=\"plainlist\"><ul><li><span title=\"www.kegg.jp\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.kegg.jp/entry/C14732\">C14732</a></span></li></ul></div>\n</td></tr>\n\n<tr>\n<td><div style=\"padding:0.1em 0;line-height:1.2em;\"><a href=\"/wiki/PubChem\" title=\"PubChem\">PubChem</a> <abbr title=\"Compound ID\">CID</abbr></div>\n</td>\n<td><div class=\"plainlist\"><ul><li><span title=\"pubchem.ncbi.nlm.nih.gov\"><a rel=\"nofollow\" class=\"external text\" href=\"https://pubchem.ncbi.nlm.nih.gov/compound/5283159\">5283159</a></span></li></ul></div>\n</td></tr>\n\n\n\n<tr>\n<td colspan=\"2\"><div class=\"NavFrame collapsed\" style=\"border: none; padding: 0;\">\n<div class=\"NavHead\" style=\"font-size: 105%; text-align:left; font-weight:normal; background:transparent;\"><a href=\"/wiki/International_Chemical_Identifier\" title=\"International Chemical Identifier\">InChI</a></div>\n<ul class=\"NavContent\" style=\"list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;\"><li style=\"line-height: inherit; margin: 0\"><div style=\"border-top:1px solid #ccc; padding:0.2em 0 0.2em 1.5em; text-align:left;\"><div style=\"word-wrap:break-word; text-indent:-1.5em; font-size:11px; line-height:120%;\">InChI=1S/C20H30O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-16-19(21)17-15-18-20(22)23/h6-7,9-10,12-14,16H,2-5,8,11,15,17-18H2,1H3,(H,22,23)/b7-6-,10-9-,13-12-,16-14+</div><div style=\"word-wrap:break-word; text-indent:-1.5em; font-size:11px; line-height:120%;\">Key:&#160;MEASLHGILYBXFO-XTDASVJISA-N</div></div></li></ul>\n</div>\n</td></tr>\n<tr>\n<td colspan=\"2\"><div class=\"NavFrame collapsed\" style=\"border: none; padding: 0;\">\n<div class=\"NavHead\" style=\"font-size: 105%; text-align:left; font-weight:normal; background:transparent;\"><a href=\"/wiki/Simplified_molecular-input_line-entry_system\" title=\"Simplified molecular-input line-entry system\">SMILES</a></div>\n<ul class=\"NavContent\" style=\"list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;\"><li style=\"line-height: inherit; margin: 0\"><div style=\"border-top:1px solid #ccc; padding:0.2em 0 0.2em 1.6em; word-wrap:break-word; text-indent:-1.5em; text-align:left; font-size:11px; line-height:120%;\">CCCCC\\C=C/C\\C=C/C\\C=C/C=C/C(=O)CCCC(O)=O</div></li></ul>\n</div>\n</td></tr>\n<tr>\n<th colspan=\"2\" style=\"background: #f8eaba; text-align: center;\">Properties\n</th></tr>\n<tr>\n<td><div style=\"padding:0.1em 0;line-height:1.2em;\"><a href=\"/wiki/Chemical_formula\" title=\"Chemical formula\">Chemical formula</a></div>\n</td>\n<td><span title=\"Carbon\">C</span><sub>20</sub><span title=\"Hydrogen\">H</span><sub>30</sub><span title=\"Oxygen\">O</span><sub>3</sub>\n</td></tr>\n<tr>\n<td><a href=\"/wiki/Molar_mass\" title=\"Molar mass\">Molar mass</a>\n</td>\n<td>318.45&#x20; &#x20;\n</td></tr>\n\n\n\n\n\n\n\n\n<tr>\n<td colspan=\"2\" style=\"text-align:left; background:#f8eaba;\"><div style=\"margin:0 auto; text-align:left;\"><div style=\"padding:0.1em 0;line-height:1.2em;\">Except where otherwise noted, data are given for materials in their <a href=\"/wiki/Standard_state\" title=\"Standard state\">standard state</a> (at 25&#160;\u00b0C [77&#160;\u00b0F], 100&#160;kPa).</div></div>\n</td></tr>\n\n\n\n<tr style=\"background:#f8eaba; border-top:2px solid transparent;\">\n<td colspan=\"2\" style=\"text-align:center;\"><a href=\"/wiki/Wikipedia:Chemical_infobox#References\" title=\"Wikipedia:Chemical infobox\">Infobox&#160;references</a>\n</td></tr>\n<tr style=\"background:#f8eaba;\">\n<td style=\"width:40%; max-height:1px; border-top:2px solid transparent; border-right:1px solid transparent;\">\n</td>\n<td style=\"width:60%; max-height:1px; border-top:2px solid transparent; border-left:1px solid transparent;\">\n</td></tr>\n</tbody></table>\n<p><b>5-Oxo-eicosatetraenoic acid</b> (i.e. 5-oxo-6<i>E</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>-eicosatetraenoic acid; also termed <b>5-oxo-ETE</b> and <b>5-oxoETE</b>) is a <a href=\"/wiki/Nonclassic_eicosanoid\" title=\"Nonclassic eicosanoid\">Nonclassic eicosanoid</a> metabolite of <a href=\"/wiki/Arachidonic_acid\" title=\"Arachidonic acid\">arachidonic acid</a> and the most potent naturally occurring member of the <a href=\"/wiki/5-HETE\" class=\"mw-redirect\" title=\"5-HETE\">5-HETE</a> family of <a href=\"/wiki/Cell_signaling\" title=\"Cell signaling\">cell signaling</a> agents.  Like other cell signaling agents, 5-oxo-ETE is made by a cell and then feeds back to stimulate its parent cell (see <a href=\"/wiki/Autocrine_signaling\" class=\"mw-redirect\" title=\"Autocrine signaling\">Autocrine signaling</a>) and/or exits this cell to stimulate nearby cells (see <a href=\"/wiki/Paracrine_signaling\" class=\"mw-redirect\" title=\"Paracrine signaling\">paracrine signaling</a>). 5-Oxo-ETE can stimulate various cell types particularly human <a href=\"/wiki/Leukocytes\" class=\"mw-redirect\" title=\"Leukocytes\">leukocytes</a> but possesses its highest potency and power in stimulating the human <a href=\"/wiki/Eosinophil\" title=\"Eosinophil\">eosinophil</a> type of leukocyte. It is therefore suggested to be formed during and to be an important contributor to the formation and progression of eosinophil-based allergic reactions;<sup id=\"cite_ref-Biochim_Biophys_Acta_2014_1-0\" class=\"reference\"><a href=\"#cite_note-Biochim_Biophys_Acta_2014-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-ReferenceA_2-0\" class=\"reference\"><a href=\"#cite_note-ReferenceA-2\">&#91;2&#93;</a></sup> it is also suggested that 5-oxo-ETE may also contribute <a href=\"/wiki/Inflammation\" title=\"Inflammation\">inflammation</a>, cancer cell growth, and other pathophysiological responses.<sup id=\"cite_ref-Biochim_Biophys_Acta_2014_1-1\" class=\"reference\"><a href=\"#cite_note-Biochim_Biophys_Acta_2014-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-Prog_Lipid_Res_2013._p_19_3-0\" class=\"reference\"><a href=\"#cite_note-Prog_Lipid_Res_2013._p_19-3\">&#91;3&#93;</a></sup>\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Biochemistry_and_production\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Biochemistry and production</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Tissue_sources\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Tissue sources</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-3\"><a href=\"#Cellular_production\"><span class=\"tocnumber\">2.1</span> <span class=\"toctext\">Cellular production</span></a></li>\n<li class=\"toclevel-2 tocsection-4\"><a href=\"#Transcellular_production\"><span class=\"tocnumber\">2.2</span> <span class=\"toctext\">Transcellular production</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#Metabolism\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Metabolism</span></a></li>\n<li class=\"toclevel-1 tocsection-6\"><a href=\"#Mechanism_of_action\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Mechanism of action</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-7\"><a href=\"#The_OXER1_receptor\"><span class=\"tocnumber\">4.1</span> <span class=\"toctext\">The OXER1 receptor</span></a></li>\n<li class=\"toclevel-2 tocsection-8\"><a href=\"#Other_GPCR_receptors\"><span class=\"tocnumber\">4.2</span> <span class=\"toctext\">Other GPCR receptors</span></a></li>\n<li class=\"toclevel-2 tocsection-9\"><a href=\"#PPAR\u03b3\"><span class=\"tocnumber\">4.3</span> <span class=\"toctext\">PPAR\u03b3</span></a></li>\n<li class=\"toclevel-2 tocsection-10\"><a href=\"#Other_mechanisms\"><span class=\"tocnumber\">4.4</span> <span class=\"toctext\">Other mechanisms</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-11\"><a href=\"#Target_cells\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">Target cells</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-12\"><a href=\"#Inflammatory_cells\"><span class=\"tocnumber\">5.1</span> <span class=\"toctext\">Inflammatory cells</span></a></li>\n<li class=\"toclevel-2 tocsection-13\"><a href=\"#Lung_airway_smooth_muscle_cells\"><span class=\"tocnumber\">5.2</span> <span class=\"toctext\">Lung airway smooth muscle cells</span></a></li>\n<li class=\"toclevel-2 tocsection-14\"><a href=\"#Cancer_cells\"><span class=\"tocnumber\">5.3</span> <span class=\"toctext\">Cancer cells</span></a></li>\n<li class=\"toclevel-2 tocsection-15\"><a href=\"#Steroidogenic_cells\"><span class=\"tocnumber\">5.4</span> <span class=\"toctext\">Steroidogenic cells</span></a></li>\n<li class=\"toclevel-2 tocsection-16\"><a href=\"#Other_cell_types\"><span class=\"tocnumber\">5.5</span> <span class=\"toctext\">Other cell types</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-17\"><a href=\"#Interaction_with_other_stimuli\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">Interaction with other stimuli</span></a></li>\n<li class=\"toclevel-1 tocsection-18\"><a href=\"#Clinical_significance\"><span class=\"tocnumber\">7</span> <span class=\"toctext\">Clinical significance</span></a></li>\n<li class=\"toclevel-1 tocsection-19\"><a href=\"#See_also\"><span class=\"tocnumber\">8</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-20\"><a href=\"#References\"><span class=\"tocnumber\">9</span> <span class=\"toctext\">References</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Biochemistry_and_production\">Biochemistry and production</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=5-oxo-eicosatetraenoic_acid&amp;action=edit&amp;section=1\" title=\"Edit section: Biochemistry and production\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>In the most common means for its production, cells make 5-oxo-ETE in a four step pathway that involves their stimulus-induced activation of the following pathway: <b>a)</b> the release of arachidonic acid (i.e. 5Z,8Z,11Z,14Z-eicosatetraenoic acid) from its storage sites in membrane <a href=\"/wiki/Phospholipids\" class=\"mw-redirect\" title=\"Phospholipids\">phospholipids</a> due to the activation of <a href=\"/wiki/Phospholipase_A2\" title=\"Phospholipase A2\">phospholipase A2</a> enzymes; <b>b)</b> oxygenation of this arachidonic acid with by activated <a href=\"/wiki/Arachidonate_5-lipoxygenase\" title=\"Arachidonate 5-lipoxygenase\">arachidonate 5-lipoxygenase</a> (ALOX5) to form 5(<i>S</i>)-hydroperoxy-6<i>E</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>-eicosatetraenoic acid (5(<i>S</i>)-HpETE); <b>c)</b> reduction of this 5(<i>S</i>)-HpETE by ubiquitous cellular peroxidases to form 5(<i>S</i>)-hydroxy-6<i>E</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>-eicosatetraenoic acid (5(<i>S</i>)-HETE); and (<b>d</b>) the oxidation of 5(<i>S</i>)-HETE by a <a href=\"/wiki/Microsome\" title=\"Microsome\">microsome</a>-bound <a href=\"/wiki/Nicotinamide_adenine_dinucleotide_phosphate\" title=\"Nicotinamide adenine dinucleotide phosphate\">nicotinamide adenine dinucleotide phosphate</a> (NADP<sup>+</sup>)-dependent dehydrogenase enzyme viz., (<a href=\"/wiki/5-Hydroxyeicosanoid_dehydrogenase\" title=\"5-Hydroxyeicosanoid dehydrogenase\">5-Hydroxyeicosanoid dehydrogenase</a> or 5-HEDH) to form 5-oxo-ETE:<sup id=\"cite_ref-Biochim_Biophys_Acta_2014_1-2\" class=\"reference\"><a href=\"#cite_note-Biochim_Biophys_Acta_2014-1\">&#91;1&#93;</a></sup>  \n</p>\n<center>\n<b>a)</b> Phospholipid-bound arachidonic acid  \u2192 free arachidonic acid</center>\n<center>\n<b>b)</b> Free arachidonic acid + O<sub>2</sub> \u2192 5<i>(S</i>)-HpETE</center>\n<center>\n<b>c)</b> 5<i>(S)</i>-HpETE \u2192 5(<i>S</i>)-HETE</center>\n<center>\n<b>d)</b> 5<i>(S)</i>-HETE + NADP<sup>+</sup>  <span class=\"mwe-math-element\"><span class=\"mwe-math-mathml-inline mwe-math-mathml-a11y\" style=\"display: none;\"><math xmlns=\"http://www.w3.org/1998/Math/MathML\"  alttext=\"{\\displaystyle \\rightleftharpoons }\">\n  <semantics>\n    <mrow class=\"MJX-TeXAtom-ORD\">\n      <mstyle displaystyle=\"true\" scriptlevel=\"0\">\n        <mo class=\"MJX-variant\" stretchy=\"false\">&#x21CC;<!-- \u21cc --></mo>\n      </mstyle>\n    </mrow>\n    <annotation encoding=\"application/x-tex\">{\\displaystyle \\rightleftharpoons }</annotation>\n  </semantics>\n</math></span><img src=\"https://wikimedia.org/api/rest_v1/media/math/render/svg/1c37b981df851b9e54e489e017b1481e37d418f3\" class=\"mwe-math-fallback-image-inline\" aria-hidden=\"true\" style=\"vertical-align: -0.338ex; width:2.324ex; height:1.843ex;\" alt=\"\\rightleftharpoons \"/></span> 5-oxo-ETE + NADPH</center>\n<p>5-HEDH has little or no ability to metabolize the <i>R</i> <a href=\"/wiki/Stereoisomer\" class=\"mw-redirect\" title=\"Stereoisomer\">stereoisomer</a> of 5(<i>S</i>)-HETE viz., 5(<i>R</i>)-HETE, to 5-oxo-ETE.  Furthermore, it acts in a fully reversible manner, readily converting 5-oxo-ETE back to 5(<i>S</i>)-HETE. Since cells typically maintain very high levels of NADPH compared to their NADP<sup>+</sup> levels, they generally have little or no ability to convert 5(<i>S</i>)-HEE to 5-oxo-ETE, and when confronted with 5-oxo-ETE rapidly metabolize it to 5(<i>S</i>)-HETE.<sup id=\"cite_ref-Biochim_Biophys_Acta_2014_1-3\" class=\"reference\"><a href=\"#cite_note-Biochim_Biophys_Acta_2014-1\">&#91;1&#93;</a></sup>  However, cells undergoing aging, senescence, <a href=\"/wiki/Apoptosis\" title=\"Apoptosis\">apoptosis</a>, <a href=\"/wiki/Oxidative_stress\" title=\"Oxidative stress\">oxidative stress</a>, or other conditions that raise their levels of <a href=\"/wiki/Reactive_oxygen_species\" title=\"Reactive oxygen species\">reactive oxygen species</a> (e.g. <a href=\"/wiki/Superoxide\" title=\"Superoxide\">superoxide</a> anion, <a href=\"/wiki/Oxygen_radicals\" class=\"mw-redirect\" title=\"Oxygen radicals\">oxygen radicals</a>, and <a href=\"/wiki/Peroxides\" class=\"mw-redirect\" title=\"Peroxides\">peroxides</a>) either physiologically (e.g. human <a href=\"/wiki/Phagocytes\" class=\"mw-redirect\" title=\"Phagocytes\">phagocytes</a> engulfing bacteria) or pathologically (e.g. oxidatively challenged <a href=\"/wiki/B-lymphocytes\" class=\"mw-redirect\" title=\"B-lymphocytes\">B-lymphocytes</a>) use up NADP<sup>+</sup>, have low NADPH/NADP<sup>+</sup> ratios, and therefore readily convert 5(<i>S</i>)-HETE to 5-oxo-ETE.<sup id=\"cite_ref-Biochim_Biophys_Acta_2014_1-4\" class=\"reference\"><a href=\"#cite_note-Biochim_Biophys_Acta_2014-1\">&#91;1&#93;</a></sup> Thus, many pathological conditions oxidative stress such as occurs in rapidly growing cancers may be important promoters of 5-oxo-ETE accumulation in vivo.\n</p><p>5-Oxo-ETE can also be made form either 5(<i>S</i>)-HpETE (and possibly 5(<i>R</i>)-HpEPE) by the action of <a href=\"/wiki/Cytochrome_P450\" title=\"Cytochrome P450\">cytochrome P450</a> (CYP) enzymes such as <a href=\"/wiki/CYP1A1\" class=\"mw-redirect\" title=\"CYP1A1\">CYP1A1</a>, <a href=\"/wiki/CYP1A2\" title=\"CYP1A2\">CYP1A2</a>, <a href=\"/wiki/CYP1B1\" title=\"CYP1B1\">CYP1B1</a>, and <a href=\"/wiki/CYP2S1\" title=\"CYP2S1\">CYP2S1</a>.<sup id=\"cite_ref-4\" class=\"reference\"><a href=\"#cite_note-4\">&#91;4&#93;</a></sup> from 5(<i>S</i>)-HETE (and probably 5(<i>R</i>)-HETE) by the non-enzymatic attack with <a href=\"/wiki/Heme\" title=\"Heme\">heme</a> or various other dehydrating agents;<sup id=\"cite_ref-Biochim_Biophys_Acta_2014_1-5\" class=\"reference\"><a href=\"#cite_note-Biochim_Biophys_Acta_2014-1\">&#91;1&#93;</a></sup> It may also form by the conversion of 5-(<i>S</i>)-HpETE or 5(<i>R</i>)-HpETE to 5-oxo-ETE due to the action of a mouse <a href=\"/wiki/Macrophage\" title=\"Macrophage\">macrophage</a> 50-60 <a href=\"/wiki/Kilodalton\" class=\"mw-redirect\" title=\"Kilodalton\">kilodalton</a> cytosolic protein.<sup id=\"cite_ref-5\" class=\"reference\"><a href=\"#cite_note-5\">&#91;5&#93;</a></sup>  The contribution of the latter three pathways to the physiological production of 5-oxo-ETE has not been fully evaluated.\n</p><p>An isomer of 5-oxo-ETE, 5-oxo-(7<i>E</i>,9<i>E</i>,11<i>Z</i>,14<i>Z</i>)-eicosatetraenoic acid, forms non-enzymatically as a byproduct of hydrolyses of the 5-lipooxgenase metabolite, <a href=\"/wiki/Leukotriene_A4\" title=\"Leukotriene A4\">Leukotriene A4</a>.  This byproduct differs from 5-oxo-ETE not only in the position and geometry of its double bounds but also in its activity: it stimulates human neutrophils apparently by acting on one or more LTB4 receptors rather than OXER1.<sup id=\"cite_ref-Biochim_Biophys_Acta_2014_1-6\" class=\"reference\"><a href=\"#cite_note-Biochim_Biophys_Acta_2014-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-6\" class=\"reference\"><a href=\"#cite_note-6\">&#91;6&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Tissue_sources\">Tissue sources</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=5-oxo-eicosatetraenoic_acid&amp;action=edit&amp;section=2\" title=\"Edit section: Tissue sources\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span class=\"mw-headline\" id=\"Cellular_production\">Cellular production</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=5-oxo-eicosatetraenoic_acid&amp;action=edit&amp;section=3\" title=\"Edit section: Cellular production\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Human <a href=\"/wiki/Neutrophil\" title=\"Neutrophil\">neutrophils</a>, <a href=\"/wiki/Monocyte\" title=\"Monocyte\">monocytes</a>, <a href=\"/wiki/Eosinophil\" title=\"Eosinophil\">eosinophils</a>, <a href=\"/wiki/B-lymphocyte\" class=\"mw-redirect\" title=\"B-lymphocyte\">B-lymphocytes</a>, <a href=\"/wiki/Dendritic_cell\" title=\"Dendritic cell\">dendritic cell</a>, <a href=\"/wiki/Platelets\" class=\"mw-redirect\" title=\"Platelets\">platelets</a>, airway <a href=\"/wiki/Epithelial_cell\" class=\"mw-redirect\" title=\"Epithelial cell\">epithelial cells</a> and <a href=\"/wiki/Smooth_muscle_cell\" class=\"mw-redirect\" title=\"Smooth muscle cell\">smooth muscle cells</a>, vascular <a href=\"/wiki/Endothelial_cell\" class=\"mw-redirect\" title=\"Endothelial cell\">endothelial cells</a>, and skin <a href=\"/wiki/Keratinocytes\" class=\"mw-redirect\" title=\"Keratinocytes\">keratinocytes</a> have been found and/or suggested to make 5-oxo-ETE from endogenous or exogenous 5-HETE, particularly under conditions of oxidative stress; cell lines derived from human cancers such as those from breast, prostate, lung, colon, and various types of leukemia have likewise been shown to be producers of 5-oxo-ETE.<sup id=\"cite_ref-Prog_Lipid_Res_2013._p_19_3-1\" class=\"reference\"><a href=\"#cite_note-Prog_Lipid_Res_2013._p_19-3\">&#91;3&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Transcellular_production\">Transcellular production</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=5-oxo-eicosatetraenoic_acid&amp;action=edit&amp;section=4\" title=\"Edit section: Transcellular production\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Cells of one type may release the 5(<i>S</i>)-HETE that they make to nearby cells of a second type which then oxidize the 5(<i>S</i>)-HETE to 5-oxo-ETE.  This <b>transcellular production</b> typically involves the limited variety of cell types that express active 5-lipoxygenase, lack HEDH activity because of their high levels of NADPH compared to NADP<sup>+</sup> levels, and therefore accumulate 5(<i>S</i>)-HETE, not 5-oxo-ETE, upon stimulation; this 5(<i>S</i>)-ETE can leaves these cells, enter various cell types that possess 5-HEDH activity along with lower NADPH to NADP<sup>+</sup> levels, and thereby is converted to 5-oxo-ETE.  This transcellular production of 5-oxo-eicosatetraenoates has been demonstrated <b>in vitro</b> with human neutrophils as the 5(<i>S</i>)-HETE producing cells and human <a href=\"/wiki/PC-3\" class=\"mw-redirect\" title=\"PC-3\">PC-3</a> prostate cancer cells, <a href=\"/wiki/Platelets\" class=\"mw-redirect\" title=\"Platelets\">platelets</a>, and <a href=\"/wiki/Monocyte\" title=\"Monocyte\">monocyte</a>-derived <a href=\"/wiki/Dendritic_cell\" title=\"Dendritic cell\">dendritic cells</a> as the oxidizing cells.<sup id=\"cite_ref-Prog_Lipid_Res_2013._p_19_3-2\" class=\"reference\"><a href=\"#cite_note-Prog_Lipid_Res_2013._p_19-3\">&#91;3&#93;</a></sup><sup id=\"cite_ref-7\" class=\"reference\"><a href=\"#cite_note-7\">&#91;7&#93;</a></sup>  It is theorized that this transcellular metabolism occurs in vivo and provides a mechanism for controlling 5-oxo-ETE production by allowing it to occur or be augmented at sites were 5-lipoxygenase-containg cells congregate with cell types possessing 5-HEDH and favorable NADPH/NADP<sup>+</sup> ratios; such sites, it is theorized, might include those involving allergy, inflammation, oxidative stress, and rapidly growing cancers.<sup id=\"cite_ref-Biochim_Biophys_Acta_2014_1-7\" class=\"reference\"><a href=\"#cite_note-Biochim_Biophys_Acta_2014-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-Prog_Lipid_Res_2013._p_19_3-3\" class=\"reference\"><a href=\"#cite_note-Prog_Lipid_Res_2013._p_19-3\">&#91;3&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Metabolism\">Metabolism</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=5-oxo-eicosatetraenoic_acid&amp;action=edit&amp;section=5\" title=\"Edit section: Metabolism\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>As indicated in the previous section, 5-oxo-ETE is readily converted to 5(<i>S</i>)-HETE by 5-HEDH in cells containing very low NADPH/NADP<sup>+</sup> ratios. Human <a href=\"/wiki/Neutrophils\" class=\"mw-redirect\" title=\"Neutrophils\">neutrophils</a>, an important model cell for investigating 5-oxo-ETE production, take up 5-oxo-ETE and reduce it to 5(<i>S</i>)-HETE; they also form appreciable amounts of 5(<i>S</i>),20-dihydroxy-ETE and small amounts of 5-oxo,20-hydroxy-ETE probably by the action of the \u03c9-hydroxylase <a href=\"/wiki/Cytochrome_P450\" title=\"Cytochrome P450\">cytochrome P450</a> enzyme, CYP453A on 5(<i>S</i>)-HETE and 5-oxo-ETE, respectively.<sup id=\"cite_ref-Prog_Lipid_Res_2013._p_19_3-4\" class=\"reference\"><a href=\"#cite_note-Prog_Lipid_Res_2013._p_19-3\">&#91;3&#93;</a></sup><sup id=\"cite_ref-ReferenceB_8-0\" class=\"reference\"><a href=\"#cite_note-ReferenceB-8\">&#91;8&#93;</a></sup> The cells also incorporate the 5(<i>S</i>)-HETE product of 5-oxo-ETE but little or no 5-oxo-ETE itself as an <a href=\"/wiki/Ester\" title=\"Ester\">ester</a> into their various <a href=\"/wiki/Phospholipid\" title=\"Phospholipid\">phospholipid</a> and <a href=\"/wiki/Glycerolipid\" class=\"mw-redirect\" title=\"Glycerolipid\">glycerolipid</a> pools; however, isolated neutrophil <a href=\"/wiki/Plasma_membrane\" class=\"mw-redirect\" title=\"Plasma membrane\">plasma membranes</a>, which lack appreciable 5-HEDH activity, do esterify 5-oxo-ETE into these lipid pools.<sup id=\"cite_ref-Biochim_Biophys_Acta_2014_1-8\" class=\"reference\"><a href=\"#cite_note-Biochim_Biophys_Acta_2014-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-ReferenceB_8-1\" class=\"reference\"><a href=\"#cite_note-ReferenceB-8\">&#91;8&#93;</a></sup>\n</p><p>Several other pathways can metabolize 5-oxo-ETE.  First, human <a href=\"/wiki/Eosinophils\" class=\"mw-redirect\" title=\"Eosinophils\">eosinophils</a> use <a href=\"/wiki/Arachidonate_15-lipoxygenase\" class=\"mw-redirect\" title=\"Arachidonate 15-lipoxygenase\">Arachidonate 15-lipoxygenase</a>-1 (or possibly <a href=\"/wiki/Arachidonate_15-lipoxygenase-2\" class=\"mw-redirect\" title=\"Arachidonate 15-lipoxygenase-2\">Arachidonate 15-lipoxygenase-2</a> to metabolize 5-oxo-ETE to 5-oxo-15-(<i>S</i>)-hydroperoxy-ETE which is rapidly reduced to 5-oxo-15(<i>S</i>)-hydroxy-ETE; 5-oxo-15(<i>S</i>)-hydroxyl-ETE is about one-third as potent as 5-oxo-ETE in stimulating cells.<sup id=\"cite_ref-Biochim_Biophys_Acta_2014_1-9\" class=\"reference\"><a href=\"#cite_note-Biochim_Biophys_Acta_2014-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-Prog_Lipid_Res_2013._p_19_3-5\" class=\"reference\"><a href=\"#cite_note-Prog_Lipid_Res_2013._p_19-3\">&#91;3&#93;</a></sup> Second, human platelets use <a href=\"/wiki/12-lipoxygenase\" class=\"mw-redirect\" title=\"12-lipoxygenase\">12-lipoxygenase</a> to metabolize 5-oxo-ETE to 5-oxo-12(<i>S</i>)-hydroperxy-eicosatetraenoat which is rapidly converted to 5-oxo-12(<i>S</i>)-hydroxy-eicosatetraenoate (5-oxo-12)<i>S</i>)-hydroxy-ETE); 5-oxo-12(<i>S</i>)-hydroxyl-ETE is a weak antagonist of 5-oxo-ETE.<sup id=\"cite_ref-Prog_Lipid_Res_2013._p_19_3-6\" class=\"reference\"><a href=\"#cite_note-Prog_Lipid_Res_2013._p_19-3\">&#91;3&#93;</a></sup> Third, mouse <a href=\"/wiki/Macrophages\" class=\"mw-redirect\" title=\"Macrophages\">macrophages</a> use <b>a)</b> a <a href=\"/wiki/Cytochrome_P450\" title=\"Cytochrome P450\">cytochrome P450</a> enzyme to metabolize 5-oxo-ETE to 5-oxo-18-hydroxy-ETE (5-oxo-18-HETE) which is either attacked by a 5-keto-reductase (possibly 5-HEDH) to form 5,18-dihydroxy-eicosatetraenoic acid (5,18-diHETE) or by a \u03946-reductase to form 5-oxo-18-hydroxy-eicosatrienoic acid (5-oxo-18-HETrE) which is then reduced by a 5-keto-reductase (possibly 5-HEDH) to 5,18-dihydroxy-eicosatetrienoic acid (5,18-diHETrE); <b>b)</b> a cytochrome P450 enzyme converts 5-oxo-ETE to 5-oxo-19-hydroxy-eicosatetraenoic acid (5-oxo-19-HETE) which is then either reduced by a keto reductase (possibly 5-HEDH) to 5,19-dihydroxy-eicosatetraenoic acid (5,19-diHETE) or by a \u03946 reductase to 5-oxo-19-hydroxy-eicosatrienoic acid (5-oxo-19-HETrE);<sup id=\"cite_ref-9\" class=\"reference\"><a href=\"#cite_note-9\">&#91;9&#93;</a></sup> or <b>c)</b> leukotriene C4 synthase to metabolize 5-oxo-ETE to 5-oxo-7-glutathionyl-8,11,14-eicosatrienoic acid (FOG7). FOG7 simulates cells by a different mechanism than 5-oxo-ETE; the biological activity of the other mouse-derived metabolites has not been reported.<sup id=\"cite_ref-10\" class=\"reference\"><a href=\"#cite_note-10\">&#91;10&#93;</a></sup><sup id=\"cite_ref-11\" class=\"reference\"><a href=\"#cite_note-11\">&#91;11&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Mechanism_of_action\">Mechanism of action</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=5-oxo-eicosatetraenoic_acid&amp;action=edit&amp;section=6\" title=\"Edit section: Mechanism of action\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span class=\"mw-headline\" id=\"The_OXER1_receptor\">The OXER1 receptor</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=5-oxo-eicosatetraenoic_acid&amp;action=edit&amp;section=7\" title=\"Edit section: The OXER1 receptor\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Studies in human neutrophils first detected a <a href=\"/wiki/Plasma_membrane\" class=\"mw-redirect\" title=\"Plasma membrane\">plasma membrane</a>-localized site which reversibly bound 5-oxo-ETE and had the attributes of a <a href=\"/wiki/Gi_alpha_subunit\" title=\"Gi alpha subunit\">Gi alpha subunit</a>-linked <a href=\"/wiki/G_protein-coupled_receptor\" title=\"G protein-coupled receptor\">G protein-coupled receptor</a> based on the ability of 5-oxo-ETE to activate this class of membrane G proteins by a <a href=\"/wiki/Pertussis_toxin\" title=\"Pertussis toxin\">pertussis toxin</a>-sensitive mechanism.<sup id=\"cite_ref-Prog_Lipid_Res_2013._p_19_3-7\" class=\"reference\"><a href=\"#cite_note-Prog_Lipid_Res_2013._p_19-3\">&#91;3&#93;</a></sup><sup id=\"cite_ref-ReferenceB_8-2\" class=\"reference\"><a href=\"#cite_note-ReferenceB-8\">&#91;8&#93;</a></sup>  Subsequently, this receptor was cloned by several groups who termed it the <a href=\"/wiki/Oxoeicosanoid_receptor_1\" title=\"Oxoeicosanoid receptor 1\">oxoeicosanoid receptor 1</a> (OXER1), OXE, OXE-R, hGPCR48, HGPCR48, or R527 (its gene is termed <i>OXE1</i> or <i>OXER1</i>), and found it coupled with and activated the <a href=\"/wiki/G_protein\" title=\"G protein\">G protein</a> complex composed of the <a href=\"/wiki/Gi_alpha_subunit\" title=\"Gi alpha subunit\">Gi alpha subunit</a> (G\u03b1i) and <a href=\"/wiki/G_beta-gamma_complex\" title=\"G beta-gamma complex\">G beta-gamma complex</a> (G\u03b2\u03b3).<sup id=\"cite_ref-Biochim_Biophys_Acta_2014_1-10\" class=\"reference\"><a href=\"#cite_note-Biochim_Biophys_Acta_2014-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-Prog_Lipid_Res_2013._p_19_3-8\" class=\"reference\"><a href=\"#cite_note-Prog_Lipid_Res_2013._p_19-3\">&#91;3&#93;</a></sup><sup id=\"cite_ref-ReferenceC_12-0\" class=\"reference\"><a href=\"#cite_note-ReferenceC-12\">&#91;12&#93;</a></sup> Based on the presence of its <a href=\"/wiki/MRNA\" class=\"mw-redirect\" title=\"MRNA\">mRNA</a>, the OXER1 <a href=\"/wiki/MRNA\" class=\"mw-redirect\" title=\"MRNA\">mRNA</a> is highly expressed in human blood <a href=\"/wiki/Eosinophils\" class=\"mw-redirect\" title=\"Eosinophils\">eosinophils</a>, neutrophils, spleen, lung, liver and kidney and at lower levels in human basophils, monocytes, lung <a href=\"/wiki/Macrophages\" class=\"mw-redirect\" title=\"Macrophages\">macrophages</a>, various cancer cell lines, and an adrenocortical cell line.<sup id=\"cite_ref-Biochim_Biophys_Acta_2014_1-11\" class=\"reference\"><a href=\"#cite_note-Biochim_Biophys_Acta_2014-1\">&#91;1&#93;</a></sup> <a href=\"/wiki/Ortholog\" class=\"mw-redirect\" title=\"Ortholog\">Orthologs</a> of OXER1 are found in various mammalian species including cats and opossums as well as several species of fish; however, mice and rats lack a clear ortholog of OXER1.<sup id=\"cite_ref-ReferenceA_2-1\" class=\"reference\"><a href=\"#cite_note-ReferenceA-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-Prog_Lipid_Res_2013._p_19_3-9\" class=\"reference\"><a href=\"#cite_note-Prog_Lipid_Res_2013._p_19-3\">&#91;3&#93;</a></sup> When bound by 5-oxo-ETE or other 5-HETE family member, OXER1 triggers this G protein complex to dissociate into its G\u03b1i and G\u03b2\u03b3 components, with G\u03b2\u03b3 being responsible for activating many of the signal pathways that lead to the cellular functional responses elicited by the 5-HETE family of agonists.<sup id=\"cite_ref-13\" class=\"reference\"><a href=\"#cite_note-13\">&#91;13&#93;</a></sup>  The cell-activation pathways stimulated by OXER1 include those evoking rises in cytosolic calcium ion levels as well as those activating <a href=\"/wiki/MAPK/ERK\" class=\"mw-redirect\" title=\"MAPK/ERK\">MAPK/ERK</a>, <a href=\"/wiki/P38_mitogen-activated_protein_kinases\" title=\"P38 mitogen-activated protein kinases\">p38 mitogen-activated protein kinases</a>, cytosolic <a href=\"/wiki/Phospholipase_A2\" title=\"Phospholipase A2\">Phospholipase A2</a>, <a href=\"/wiki/PI3K\" class=\"mw-redirect\" title=\"PI3K\">PI3K</a>/<a href=\"/wiki/Akt\" class=\"mw-redirect\" title=\"Akt\">Akt</a>, <a href=\"/wiki/Protein_kinase_C\" title=\"Protein kinase C\">protein kinase C</a> beta (PKC\u03b2), and (PKC\u03b5).<sup id=\"cite_ref-Biochim_Biophys_Acta_2014_1-12\" class=\"reference\"><a href=\"#cite_note-Biochim_Biophys_Acta_2014-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-Prog_Lipid_Res_2013._p_19_3-10\" class=\"reference\"><a href=\"#cite_note-Prog_Lipid_Res_2013._p_19-3\">&#91;3&#93;</a></sup><sup id=\"cite_ref-ReferenceC_12-1\" class=\"reference\"><a href=\"#cite_note-ReferenceC-12\">&#91;12&#93;</a></sup><sup id=\"cite_ref-14\" class=\"reference\"><a href=\"#cite_note-14\">&#91;14&#93;</a></sup>  Most actions of the 5-HETE family of agonists appear mediated by OXER1. Some of their actions, however, appear to be OXER1-independent, as indicated below.\n</p>\n<h3><span class=\"mw-headline\" id=\"Other_GPCR_receptors\">Other GPCR receptors</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=5-oxo-eicosatetraenoic_acid&amp;action=edit&amp;section=8\" title=\"Edit section: Other GPCR receptors\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Mouse MA-10 cells respond to 5-oxo-ETE but lack OXER1.  It has been suggested that these cells' responses to 5-oxo-ETE are mediated by an ortholog to OXER1, mouse <a href=\"/wiki/Niacin_receptor_1\" class=\"mw-redirect\" title=\"Niacin receptor 1\">niacin receptor 1</a>, Niacr1, which is a G protein-coupled receptor for <a href=\"/wiki/Niacin\" title=\"Niacin\">niacin</a>, or, alternatively, by one or more of the mouse hydroxycarboxylic acid (HCA) family of the G protein-coupled receptors, HCA1 (<a href=\"/wiki/GPR81\" class=\"mw-redirect\" title=\"GPR81\">GPR81</a>), HCA2 (<a href=\"/wiki/GPR109A\" class=\"mw-redirect\" title=\"GPR109A\">GPR109A</a>), and HCA3 (<a href=\"/wiki/GPR109B\" class=\"mw-redirect\" title=\"GPR109B\">GPR109B</a>), which are G protein-coupled receptors for fatty acids.<sup id=\"cite_ref-Prog_Lipid_Res_2013._p_19_3-11\" class=\"reference\"><a href=\"#cite_note-Prog_Lipid_Res_2013._p_19-3\">&#91;3&#93;</a></sup><sup id=\"cite_ref-pmid23159987_15-0\" class=\"reference\"><a href=\"#cite_note-pmid23159987-15\">&#91;15&#93;</a></sup>\n</p>\n<h3><span id=\"PPAR.CE.B3\"></span><span class=\"mw-headline\" id=\"PPAR\u03b3\">PPAR\u03b3</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=5-oxo-eicosatetraenoic_acid&amp;action=edit&amp;section=9\" title=\"Edit section: PPAR\u03b3\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>5-Oxo-ETE and 5-oxo-15(<i>S</i>)-hydroxy-ETE but not 5-hydroxy members of the 5-HETE family such as 5-(<i>S</i>)-HETE activate <a href=\"/wiki/Peroxisome_proliferator-activated_receptor_gamma\" title=\"Peroxisome proliferator-activated receptor gamma\">peroxisome proliferator-activated receptor gamma</a> (PPAR\u03b3).  This activation does not proceed through OXER1; rather, it involves the direct binding of the oxo analog to PPAR\u03b3 with 5-oxo-15-(<i>S</i>)-hydroxy-ETE being more potent than 5-oxo-ETE in binding and activating PPAR\u03b3.<sup id=\"cite_ref-Biochim._Biophys_2005_16-0\" class=\"reference\"><a href=\"#cite_note-Biochim._Biophys_2005-16\">&#91;16&#93;</a></sup>  The Activation of OXER1 receptor and PPAR\u03b3 by the oxo analogs can have opposing effects on cell function.  For example, 5-oxo-ETE-bound OXER1 stimulates whereas 5-oxo-ETE-bound PPAR\u03b3 inhibits the proliferation of various types of human cancer cell lines; this results in 5-oxo-ETE and 5-oxo-15-(<i>S</i>)-HETE having considerably less potency than anticipated in stimulating these cancer cells to proliferate relative to the potency of 5-(<i>S</i>)-HETE, a relationship not closely following the potencies of these three compounds in activating OXER1.<sup id=\"cite_ref-Prog_Lipid_Res_2013._p_19_3-12\" class=\"reference\"><a href=\"#cite_note-Prog_Lipid_Res_2013._p_19-3\">&#91;3&#93;</a></sup><sup id=\"cite_ref-Biochim._Biophys_2005_16-1\" class=\"reference\"><a href=\"#cite_note-Biochim._Biophys_2005-16\">&#91;16&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Other_mechanisms\">Other mechanisms</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=5-oxo-eicosatetraenoic_acid&amp;action=edit&amp;section=10\" title=\"Edit section: Other mechanisms\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>5-Oxo-ETE relaxes pre-contracted human bronchi by a mechanism that does not appear to involve OXER1 but is otherwise undefined.<sup id=\"cite_ref-Prog_Lipid_Res_2013._p_19_3-13\" class=\"reference\"><a href=\"#cite_note-Prog_Lipid_Res_2013._p_19-3\">&#91;3&#93;</a></sup><sup id=\"cite_ref-pmid17499751_17-0\" class=\"reference\"><a href=\"#cite_note-pmid17499751-17\">&#91;17&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Target_cells\">Target cells</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=5-oxo-eicosatetraenoic_acid&amp;action=edit&amp;section=11\" title=\"Edit section: Target cells\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span class=\"mw-headline\" id=\"Inflammatory_cells\">Inflammatory cells</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=5-oxo-eicosatetraenoic_acid&amp;action=edit&amp;section=12\" title=\"Edit section: Inflammatory cells\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>5-Oxo-ETE is a potent in vitro stimulator and/or enhancer of <a href=\"/wiki/Chemotaxis\" title=\"Chemotaxis\">chemotaxis</a> (i.e. directional migration) and, depending on the cell type, various other responses such as <a href=\"/wiki/Degranulation\" title=\"Degranulation\">degranulation</a> (i.e. release of granule-bound enzymes), oxidative metabolism (i.e. generation of <a href=\"/wiki/Reactive_oxygen_species\" title=\"Reactive oxygen species\">reactive oxygen species</a>), and production of mediators such as various arachidonic acid metabolites and <a href=\"/wiki/Platelet-activating_factor\" title=\"Platelet-activating factor\">platelet-activating factor</a> in human eosinophils, <a href=\"/wiki/Basophil\" title=\"Basophil\">basophils</a>, neutrophils, and <a href=\"/wiki/Monocyte\" title=\"Monocyte\">monocytes</a>.<sup id=\"cite_ref-Prog_Lipid_Res_2013._p_19_3-14\" class=\"reference\"><a href=\"#cite_note-Prog_Lipid_Res_2013._p_19-3\">&#91;3&#93;</a></sup><sup id=\"cite_ref-pmid8906847_18-0\" class=\"reference\"><a href=\"#cite_note-pmid8906847-18\">&#91;18&#93;</a></sup> Furthermore, the injection of 5-oxo-ETE into the skin of humans causes the local accumulation of circulating blood cells, particularly  eosinophils but also to lesser extents neutrophils and <a href=\"/wiki/Monocyte\" title=\"Monocyte\">monocyte</a>-derived <a href=\"/wiki/Macrophages\" class=\"mw-redirect\" title=\"Macrophages\">macrophages</a>.<sup id=\"cite_ref-19\" class=\"reference\"><a href=\"#cite_note-19\">&#91;19&#93;</a></sup> The activity of 5-oxo-ETE on the two cell types known to be involved in allergy-based inflammation, eosinophils and basophils, suggests that it may be involved in promoting allergic reactions possibly by attracting through <a href=\"/wiki/Chemotaxis\" title=\"Chemotaxis\">chemotaxis</a> these cells to nascent sites of allergy and/or through stimulating these cells to release granule-bound enzymes, reactive oxygen species, or other promoters of allergic reactions.<sup id=\"cite_ref-Prog_Lipid_Res_2013._p_19_3-15\" class=\"reference\"><a href=\"#cite_note-Prog_Lipid_Res_2013._p_19-3\">&#91;3&#93;</a></sup><sup id=\"cite_ref-ReferenceC_12-2\" class=\"reference\"><a href=\"#cite_note-ReferenceC-12\">&#91;12&#93;</a></sup>  5-Oxo-ETE's activity on human cells involved in non-allergic inflammatory diseases viz., neutrophils and monocytes, as well as its ability to attack these cell types to the skin of humans suggest that 5-oxo-ETE may also be involved in the broad category of non-allergic inflammatory diseases including those involving host defense against pathogens.<sup id=\"cite_ref-ReferenceC_12-3\" class=\"reference\"><a href=\"#cite_note-ReferenceC-12\">&#91;12&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Lung_airway_smooth_muscle_cells\">Lung airway smooth muscle cells</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=5-oxo-eicosatetraenoic_acid&amp;action=edit&amp;section=13\" title=\"Edit section: Lung airway smooth muscle cells\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>5-Oxo-ETE contracts smooth muscle and organ-cultured bronchi isolated from guinea pigs but relaxes bronchi isolated from human lung; the relaxation of human bronchi caused by 5-oxo-ETE may not involve its OXER1.<sup id=\"cite_ref-Prog_Lipid_Res_2013._p_19_3-16\" class=\"reference\"><a href=\"#cite_note-Prog_Lipid_Res_2013._p_19-3\">&#91;3&#93;</a></sup><sup id=\"cite_ref-20\" class=\"reference\"><a href=\"#cite_note-20\">&#91;20&#93;</a></sup>  These results suggest that 5-oxo-ETE is not directly involved in the <a href=\"/wiki/Bronchoconstriction\" title=\"Bronchoconstriction\">bronchoconstriction</a>) that occurs in eosinophil-based allergic <a href=\"/wiki/Asthma\" title=\"Asthma\">asthma</a> reactions in humans.\n</p>\n<h3><span class=\"mw-headline\" id=\"Cancer_cells\">Cancer cells</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=5-oxo-eicosatetraenoic_acid&amp;action=edit&amp;section=14\" title=\"Edit section: Cancer cells\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>5-Oxo-ETE (or other 5-HETE family member) stimulates the growth and/or survival of human cell lines derived from cancers of the prostate, breast, lung, ovary, colon and pancreas<sup id=\"cite_ref-Biochim_Biophys_Acta_2014_1-13\" class=\"reference\"><a href=\"#cite_note-Biochim_Biophys_Acta_2014-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-Prog_Lipid_Res_2013._p_19_3-17\" class=\"reference\"><a href=\"#cite_note-Prog_Lipid_Res_2013._p_19-3\">&#91;3&#93;</a></sup><sup id=\"cite_ref-Biochim._Biophys_2005_16-2\" class=\"reference\"><a href=\"#cite_note-Biochim._Biophys_2005-16\">&#91;16&#93;</a></sup><sup id=\"cite_ref-21\" class=\"reference\"><a href=\"#cite_note-21\">&#91;21&#93;</a></sup> These preclinical studies suggest that 5-oxo-ETE (or other 5-HETE family member) may contribute to the cited cancers progression in humans.\n</p>\n<h3><span class=\"mw-headline\" id=\"Steroidogenic_cells\">Steroidogenic cells</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=5-oxo-eicosatetraenoic_acid&amp;action=edit&amp;section=15\" title=\"Edit section: Steroidogenic cells\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>5-oxo-ETE stimulates human <a href=\"/wiki/H295R\" title=\"H295R\">H295R</a> adrenocortical cells to increase transcription of steroidogenic acute regulatory protein messenger RNA and produce <a href=\"/wiki/Aldosterone\" title=\"Aldosterone\">aldosterone</a> and <a href=\"/wiki/Progesterone\" title=\"Progesterone\">progesterone</a> by an apparent OXER1-dependent pathway.<sup id=\"cite_ref-pmid23159987_15-1\" class=\"reference\"><a href=\"#cite_note-pmid23159987-15\">&#91;15&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Other_cell_types\">Other cell types</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=5-oxo-eicosatetraenoic_acid&amp;action=edit&amp;section=16\" title=\"Edit section: Other cell types\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>5-Oxo-ETE induces an isotonic volume reduction in guinea pig intestinal crypt epithelial cells.<sup id=\"cite_ref-22\" class=\"reference\"><a href=\"#cite_note-22\">&#91;22&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Interaction_with_other_stimuli\">Interaction with other stimuli</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=5-oxo-eicosatetraenoic_acid&amp;action=edit&amp;section=17\" title=\"Edit section: Interaction with other stimuli\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>5-Oxo-ETE and another potential mediator of human allergic reactions, <a href=\"/wiki/Platelet-activating_factor\" title=\"Platelet-activating factor\">platelet-activating factor</a>, act in <a href=\"/wiki/Synergy\" title=\"Synergy\">synergy</a> in stimulating human eosinophils and neutrophils: the combined agents elicit responses that are greater than the simple sum of their individual actions and do so at relatively low.<sup id=\"cite_ref-pmid8683135_23-0\" class=\"reference\"><a href=\"#cite_note-pmid8683135-23\">&#91;23&#93;</a></sup><sup id=\"cite_ref-pmid7803484_24-0\" class=\"reference\"><a href=\"#cite_note-pmid7803484-24\">&#91;24&#93;</a></sup> 5-Oxo-ETE also greatly increases the potencies of <a href=\"/wiki/Complement_component_5a\" title=\"Complement component 5a\">complement component 5a</a>, <a href=\"/wiki/LTB4\" class=\"mw-redirect\" title=\"LTB4\">LTB4</a>, and <a href=\"/wiki/FMLP\" class=\"mw-redirect\" title=\"FMLP\">FMLP</a> in stimulating human eosinophils to degranulate and its degranulating activity is greatly increase by pretreating human eosinophils with <a href=\"/wiki/Granulocyte-macrophage_colony_stimulating_factor\" class=\"mw-redirect\" title=\"Granulocyte-macrophage colony stimulating factor\">granulocyte-macrophage colony stimulating factor</a> or human neutrophils with either the latter <a href=\"/wiki/Cytokine\" title=\"Cytokine\">cytokine</a> or with <a href=\"/wiki/Granulocyte_colony-stimulating_factor\" title=\"Granulocyte colony-stimulating factor\">granulocyte colony-stimulating factor</a>, <a href=\"/wiki/Tumor_necrosis_factor_%CE%B1\" class=\"mw-redirect\" title=\"Tumor necrosis factor \u03b1\">tumor necrosis factor \u03b1</a>, or various <a href=\"/wiki/Nucleotides\" class=\"mw-redirect\" title=\"Nucleotides\">nucleotides</a> including <a href=\"/wiki/Adenosine_triphosphate\" title=\"Adenosine triphosphate\">ATP</a>.<sup id=\"cite_ref-pmid8683135_23-1\" class=\"reference\"><a href=\"#cite_note-pmid8683135-23\">&#91;23&#93;</a></sup><sup id=\"cite_ref-pmid7803484_24-1\" class=\"reference\"><a href=\"#cite_note-pmid7803484-24\">&#91;24&#93;</a></sup><sup id=\"cite_ref-25\" class=\"reference\"><a href=\"#cite_note-25\">&#91;25&#93;</a></sup><sup id=\"cite_ref-26\" class=\"reference\"><a href=\"#cite_note-26\">&#91;26&#93;</a></sup>  Pretreament of eosinophils with <a href=\"/wiki/Interleukin_5\" title=\"Interleukin 5\">interleukin 5</a> (a key mediator in eosinophil activation) also increases their in vitro chemotactic response to 5-oxo-ETE.<sup id=\"cite_ref-27\" class=\"reference\"><a href=\"#cite_note-27\">&#91;27&#93;</a></sup> 5-Oxo-ETE also acts in synergy with two <a href=\"/wiki/Chemokines\" class=\"mw-redirect\" title=\"Chemokines\">chemokines</a>, <a href=\"/wiki/CCL2\" title=\"CCL2\">CCL2</a> and <a href=\"/wiki/CCL8\" title=\"CCL8\">CCL8</a>, in stimulating monocyte chemotaxis.<sup id=\"cite_ref-pmid8906847_18-1\" class=\"reference\"><a href=\"#cite_note-pmid8906847-18\">&#91;18&#93;</a></sup>  The interactions of 5-oxo-ETE with these mediators of allergy (e.g. platelet-activating factor, interleukin 5) in eosinophils further suggests that it plays a role in allergic diseases while its interactions with mediators of inflammatory reactions (e.g. tumor necrosis factor \u03b1, the colony stimulating factors, and the two CCL chemokines) in neutrophils and monocytes further suggest that it plays a role in inflammatory responses and host defense mechanisms.\n</p>\n<h2><span class=\"mw-headline\" id=\"Clinical_significance\">Clinical significance</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=5-oxo-eicosatetraenoic_acid&amp;action=edit&amp;section=18\" title=\"Edit section: Clinical significance\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Essentially all of the studies on 5-oxo-ETE's activities and target cells, similar to those on other members of the 5(<i>S</i>)-HETE family of agonists, are best classified as <a href=\"/wiki/Pre-clinical_development\" title=\"Pre-clinical development\">pre-clinical development</a> studies: they have not yet been determined to be important in human pathophysiology. <a href=\"/wiki/Translation_studies\" title=\"Translation studies\">Translation studies</a> are needed to learn if the preclinical studies implicating 5-Oxo-ETE and other 5(<i>S</i>)-HETE family members in allergic diseases, inflammatory diseases, cancer, steroid production, bone remodeling, parturition, and other pathophysiological events, as outlined here and on the <a href=\"/wiki/5-HETE\" class=\"mw-redirect\" title=\"5-HETE\">5-HETE</a> page, are relevant to humans and therefore of clinical significance.\n</p>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=5-oxo-eicosatetraenoic_acid&amp;action=edit&amp;section=19\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a href=\"/wiki/ALOX15\" title=\"ALOX15\">ALOX15</a></li>\n<li><a href=\"/wiki/5-Hydroxyeicosanoid_dehydrogenase\" title=\"5-Hydroxyeicosanoid dehydrogenase\">5-Hydroxyeicosanoid dehydrogenase</a></li>\n<li><a href=\"/wiki/5-HETE\" class=\"mw-redirect\" title=\"5-HETE\">5-HETE</a></li>\n<li><a href=\"/wiki/OXER1\" class=\"mw-redirect\" title=\"OXER1\">OXER1</a></li></ul>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=5-oxo-eicosatetraenoic_acid&amp;action=edit&amp;section=20\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist columns references-column-width\" style=\"-moz-column-width: 33em; -webkit-column-width: 33em; column-width: 33em; list-style-type: decimal;\">\n<ol class=\"references\">\n<li id=\"cite_note-Biochim_Biophys_Acta_2014-1\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Biochim_Biophys_Acta_2014_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Biochim_Biophys_Acta_2014_1-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Biochim_Biophys_Acta_2014_1-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Biochim_Biophys_Acta_2014_1-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-Biochim_Biophys_Acta_2014_1-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-Biochim_Biophys_Acta_2014_1-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-Biochim_Biophys_Acta_2014_1-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-Biochim_Biophys_Acta_2014_1-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-Biochim_Biophys_Acta_2014_1-8\"><sup><i><b>i</b></i></sup></a> <a href=\"#cite_ref-Biochim_Biophys_Acta_2014_1-9\"><sup><i><b>j</b></i></sup></a> <a href=\"#cite_ref-Biochim_Biophys_Acta_2014_1-10\"><sup><i><b>k</b></i></sup></a> <a href=\"#cite_ref-Biochim_Biophys_Acta_2014_1-11\"><sup><i><b>l</b></i></sup></a> <a href=\"#cite_ref-Biochim_Biophys_Acta_2014_1-12\"><sup><i><b>m</b></i></sup></a> <a href=\"#cite_ref-Biochim_Biophys_Acta_2014_1-13\"><sup><i><b>n</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Powell WS, Rokach J (April 2015). \"Biosynthesis, biological effects, and receptors of hydroxyeicosatetraenoic acids (HETEs) and oxoeicosatetraenoic acids (oxo-ETEs) derived from arachidonic acid\". <i>Biochimica et Biophysica Acta</i>. <b>1851</b> (4): 340\u201355. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.bbalip.2014.10.008\">10.1016/j.bbalip.2014.10.008</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25449650\">25449650</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biochimica+et+Biophysica+Acta&amp;rft.atitle=Biosynthesis%2C+biological+effects%2C+and+receptors+of+hydroxyeicosatetraenoic+acids+%28HETEs%29+and+oxoeicosatetraenoic+acids+%28oxo-ETEs%29+derived+from+arachidonic+acid&amp;rft.volume=1851&amp;rft.issue=4&amp;rft.pages=340-55&amp;rft.date=2015-04&amp;rft_id=info%3Adoi%2F10.1016%2Fj.bbalip.2014.10.008&amp;rft_id=info%3Apmid%2F25449650&amp;rft.aulast=Powell&amp;rft.aufirst=WS&amp;rft.au=Rokach%2C+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3A5-oxo-eicosatetraenoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-ReferenceA-2\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-ReferenceA_2-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-ReferenceA_2-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Cossette C, Gravel S, Reddy CN, Gore V, Chourey S, Ye Q, Snyder NW, Mesaros CA, Blair IA, Lavoie JP, Reinero CR, Rokach J, Powell WS (August 2015). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4830392\">\"Biosynthesis and actions of 5-oxoeicosatetraenoic acid (5-oxo-ETE) on feline granulocytes\"</a>. <i>Biochemical Pharmacology</i>. <b>96</b> (3): 247\u201355. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.bcp.2015.05.009\">10.1016/j.bcp.2015.05.009</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4830392\">4830392</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/26032638\">26032638</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biochemical+Pharmacology&amp;rft.atitle=Biosynthesis+and+actions+of+5-oxoeicosatetraenoic+acid+%285-oxo-ETE%29+on+feline+granulocytes&amp;rft.volume=96&amp;rft.issue=3&amp;rft.pages=247-55&amp;rft.date=2015-08&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4830392&amp;rft_id=info%3Apmid%2F26032638&amp;rft_id=info%3Adoi%2F10.1016%2Fj.bcp.2015.05.009&amp;rft.aulast=Cossette&amp;rft.aufirst=C&amp;rft.au=Gravel%2C+S&amp;rft.au=Reddy%2C+CN&amp;rft.au=Gore%2C+V&amp;rft.au=Chourey%2C+S&amp;rft.au=Ye%2C+Q&amp;rft.au=Snyder%2C+NW&amp;rft.au=Mesaros%2C+CA&amp;rft.au=Blair%2C+IA&amp;rft.au=Lavoie%2C+JP&amp;rft.au=Reinero%2C+CR&amp;rft.au=Rokach%2C+J&amp;rft.au=Powell%2C+WS&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4830392&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3A5-oxo-eicosatetraenoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Prog_Lipid_Res_2013._p_19-3\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Prog_Lipid_Res_2013._p_19_3-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Prog_Lipid_Res_2013._p_19_3-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Prog_Lipid_Res_2013._p_19_3-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Prog_Lipid_Res_2013._p_19_3-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-Prog_Lipid_Res_2013._p_19_3-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-Prog_Lipid_Res_2013._p_19_3-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-Prog_Lipid_Res_2013._p_19_3-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-Prog_Lipid_Res_2013._p_19_3-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-Prog_Lipid_Res_2013._p_19_3-8\"><sup><i><b>i</b></i></sup></a> <a href=\"#cite_ref-Prog_Lipid_Res_2013._p_19_3-9\"><sup><i><b>j</b></i></sup></a> <a href=\"#cite_ref-Prog_Lipid_Res_2013._p_19_3-10\"><sup><i><b>k</b></i></sup></a> <a href=\"#cite_ref-Prog_Lipid_Res_2013._p_19_3-11\"><sup><i><b>l</b></i></sup></a> <a href=\"#cite_ref-Prog_Lipid_Res_2013._p_19_3-12\"><sup><i><b>m</b></i></sup></a> <a href=\"#cite_ref-Prog_Lipid_Res_2013._p_19_3-13\"><sup><i><b>n</b></i></sup></a> <a href=\"#cite_ref-Prog_Lipid_Res_2013._p_19_3-14\"><sup><i><b>o</b></i></sup></a> <a href=\"#cite_ref-Prog_Lipid_Res_2013._p_19_3-15\"><sup><i><b>p</b></i></sup></a> <a href=\"#cite_ref-Prog_Lipid_Res_2013._p_19_3-16\"><sup><i><b>q</b></i></sup></a> <a href=\"#cite_ref-Prog_Lipid_Res_2013._p_19_3-17\"><sup><i><b>r</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Powell WS, Rokach J (October 2013). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5710732\">\"The eosinophil chemoattractant 5-oxo-ETE and the OXE receptor\"</a>. <i>Progress in Lipid Research</i>. <b>52</b> (4): 651\u201365. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.plipres.2013.09.001\">10.1016/j.plipres.2013.09.001</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5710732\">5710732</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/24056189\">24056189</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Progress+in+Lipid+Research&amp;rft.atitle=The+eosinophil+chemoattractant+5-oxo-ETE+and+the+OXE+receptor&amp;rft.volume=52&amp;rft.issue=4&amp;rft.pages=651-65&amp;rft.date=2013-10&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5710732&amp;rft_id=info%3Apmid%2F24056189&amp;rft_id=info%3Adoi%2F10.1016%2Fj.plipres.2013.09.001&amp;rft.aulast=Powell&amp;rft.aufirst=WS&amp;rft.au=Rokach%2C+J&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5710732&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3A5-oxo-eicosatetraenoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bui P, Imaizumi S, Beedanagari SR, Reddy ST, Hankinson O (February 2011). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3033693\">\"Human CYP2S1 metabolizes cyclooxygenase- and lipoxygenase-derived eicosanoids\"</a>. <i>Drug Metabolism and Disposition</i>. <b>39</b> (2): 180\u201390. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1124/dmd.110.035121\">10.1124/dmd.110.035121</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3033693\">3033693</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21068195\">21068195</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Drug+Metabolism+and+Disposition&amp;rft.atitle=Human+CYP2S1+metabolizes+cyclooxygenase-+and+lipoxygenase-derived+eicosanoids&amp;rft.volume=39&amp;rft.issue=2&amp;rft.pages=180-90&amp;rft.date=2011-02&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3033693&amp;rft_id=info%3Apmid%2F21068195&amp;rft_id=info%3Adoi%2F10.1124%2Fdmd.110.035121&amp;rft.aulast=Bui&amp;rft.aufirst=P&amp;rft.au=Imaizumi%2C+S&amp;rft.au=Beedanagari%2C+SR&amp;rft.au=Reddy%2C+ST&amp;rft.au=Hankinson%2C+O&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3033693&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3A5-oxo-eicosatetraenoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-5\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Zarini S, Murphy RC (March 2003). \"Biosynthesis of 5-oxo-6,8,11,14-eicosatetraenoic acid from 5-hydroperoxyeicosatetraenoic acid in the murine macrophage\". <i>The Journal of Biological Chemistry</i>. <b>278</b> (13): 11190\u20136. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1074/jbc.M208496200\">10.1074/jbc.M208496200</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/12547823\">12547823</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Biological+Chemistry&amp;rft.atitle=Biosynthesis+of+5-oxo-6%2C8%2C11%2C14-eicosatetraenoic+acid+from+5-hydroperoxyeicosatetraenoic+acid+in+the+murine+macrophage&amp;rft.volume=278&amp;rft.issue=13&amp;rft.pages=11190-6&amp;rft.date=2003-03&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.M208496200&amp;rft_id=info%3Apmid%2F12547823&amp;rft.aulast=Zarini&amp;rft.aufirst=S&amp;rft.au=Murphy%2C+RC&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3A5-oxo-eicosatetraenoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-6\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Falgueyret J, Riendeau D (February 2000). \"LTA(4)-derived 5-oxo-eicosatetraenoic acid: pH-dependent formation and interaction with the LTB(4) receptor of human polymorphonuclear leukocytes\". <i>Biochimica et Biophysica Acta</i>. <b>1484</b> (1): 51\u20138. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/s1388-1981%2899%2900198-5\">10.1016/s1388-1981(99)00198-5</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/10685030\">10685030</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biochimica+et+Biophysica+Acta&amp;rft.atitle=LTA%284%29-derived+5-oxo-eicosatetraenoic+acid%3A+pH-dependent+formation+and+interaction+with+the+LTB%284%29+receptor+of+human+polymorphonuclear+leukocytes&amp;rft.volume=1484&amp;rft.issue=1&amp;rft.pages=51-8&amp;rft.date=2000-02&amp;rft_id=info%3Adoi%2F10.1016%2Fs1388-1981%2899%2900198-5&amp;rft_id=info%3Apmid%2F10685030&amp;rft.aulast=Falgueyret&amp;rft.aufirst=J&amp;rft.au=Riendeau%2C+D&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3A5-oxo-eicosatetraenoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-7\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Zimpfer U, Dichmann S, Termeer CC, Simon JC, Schr\u00f6der JM, Norgauer J (November 2000). \"Human dendritic cells are a physiological source of the chemotactic arachidonic acid metabolite 5-oxo-eicosatetraenoic acid\". <i>Inflammation Research</i>. <b>49</b> (11): 633\u20138. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s000110050641\">10.1007/s000110050641</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11131304\">11131304</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Inflammation+Research&amp;rft.atitle=Human+dendritic+cells+are+a+physiological+source+of+the+chemotactic+arachidonic+acid+metabolite+5-oxo-eicosatetraenoic+acid&amp;rft.volume=49&amp;rft.issue=11&amp;rft.pages=633-8&amp;rft.date=2000-11&amp;rft_id=info%3Adoi%2F10.1007%2Fs000110050641&amp;rft_id=info%3Apmid%2F11131304&amp;rft.aulast=Zimpfer&amp;rft.aufirst=U&amp;rft.au=Dichmann%2C+S&amp;rft.au=Termeer%2C+CC&amp;rft.au=Simon%2C+JC&amp;rft.au=Schr%C3%B6der%2C+JM&amp;rft.au=Norgauer%2C+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3A5-oxo-eicosatetraenoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-ReferenceB-8\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-ReferenceB_8-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-ReferenceB_8-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-ReferenceB_8-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">O'Flaherty JT, Taylor JS, Thomas MJ (December 1998). \"Receptors for the 5-oxo class of eicosanoids in neutrophils\". <i>The Journal of Biological Chemistry</i>. <b>273</b> (49): 32535\u201341. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1074/jbc.273.49.32535\">10.1074/jbc.273.49.32535</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9829988\">9829988</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Biological+Chemistry&amp;rft.atitle=Receptors+for+the+5-oxo+class+of+eicosanoids+in+neutrophils&amp;rft.volume=273&amp;rft.issue=49&amp;rft.pages=32535-41&amp;rft.date=1998-12&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.273.49.32535&amp;rft_id=info%3Apmid%2F9829988&amp;rft.aulast=O%27Flaherty&amp;rft.aufirst=JT&amp;rft.au=Taylor%2C+JS&amp;rft.au=Thomas%2C+MJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3A5-oxo-eicosatetraenoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-9\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-9\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Hevko JM, Bowers RC, Murphy RC (February 2001). \"Synthesis of 5-oxo-6,8,11,14-eicosatetraenoic acid and identification of novel omega-oxidized metabolites in the mouse macrophage\". <i>The Journal of Pharmacology and Experimental Therapeutics</i>. <b>296</b> (2): 293\u2013305. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11160610\">11160610</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Pharmacology+and+Experimental+Therapeutics&amp;rft.atitle=Synthesis+of+5-oxo-6%2C8%2C11%2C14-eicosatetraenoic+acid+and+identification+of+novel+omega-oxidized+metabolites+in+the+mouse+macrophage&amp;rft.volume=296&amp;rft.issue=2&amp;rft.pages=293-305&amp;rft.date=2001-02&amp;rft_id=info%3Apmid%2F11160610&amp;rft.aulast=Hevko&amp;rft.aufirst=JM&amp;rft.au=Bowers%2C+RC&amp;rft.au=Murphy%2C+RC&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3A5-oxo-eicosatetraenoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-10\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-10\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Murphy RC, Zarini S (2002). \"Glutathione adducts of oxyeicosanoids\". <i>Prostaglandins Other Lipid Mediat</i>. 68\u201369: 471\u201382. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/s0090-6980%2802%2900049-7\">10.1016/s0090-6980(02)00049-7</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/12432937\">12432937</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Prostaglandins+Other+Lipid+Mediat.&amp;rft.atitle=Glutathione+adducts+of+oxyeicosanoids&amp;rft.volume=68%E2%80%9369&amp;rft.pages=471-82&amp;rft.date=2002&amp;rft_id=info%3Adoi%2F10.1016%2Fs0090-6980%2802%2900049-7&amp;rft_id=info%3Apmid%2F12432937&amp;rft.aulast=Murphy&amp;rft.aufirst=RC&amp;rft.au=Zarini%2C+S&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3A5-oxo-eicosatetraenoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-11\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-11\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Hevko JM, Bowers RC, Murphy RC (Feb 2001). \"Synthesis of 5-oxo-6,8,11,14-eicosatetraenoic acid and identification of novel omega-oxidized metabolites in the mouse macrophage\". <i>J Pharmacol Exp Ther</i>. <b>296</b> (2): 293\u2013305. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11160610\">11160610</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Pharmacol+Exp+Ther&amp;rft.atitle=Synthesis+of+5-oxo-6%2C8%2C11%2C14-eicosatetraenoic+acid+and+identification+of+novel+omega-oxidized+metabolites+in+the+mouse+macrophage.&amp;rft.volume=296&amp;rft.issue=2&amp;rft.pages=293-305&amp;rft.date=2001-02&amp;rft_id=info%3Apmid%2F11160610&amp;rft.aulast=Hevko&amp;rft.aufirst=JM&amp;rft.au=Bowers%2C+RC&amp;rft.au=Murphy%2C+RC&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3A5-oxo-eicosatetraenoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-ReferenceC-12\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-ReferenceC_12-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-ReferenceC_12-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-ReferenceC_12-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-ReferenceC_12-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Brink C, Dahl\u00e9n SE, Drazen J, Evans JF, Hay DW, Rovati GE, Serhan CN, Shimizu T, Yokomizo T (March 2004). \"International Union of Pharmacology XLIV. Nomenclature for the oxoeicosanoid receptor\". <i>Pharmacological Reviews</i>. <b>56</b> (1): 149\u201357. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1124/pr.56.1.4\">10.1124/pr.56.1.4</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15001665\">15001665</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pharmacological+Reviews&amp;rft.atitle=International+Union+of+Pharmacology+XLIV.+Nomenclature+for+the+oxoeicosanoid+receptor&amp;rft.volume=56&amp;rft.issue=1&amp;rft.pages=149-57&amp;rft.date=2004-03&amp;rft_id=info%3Adoi%2F10.1124%2Fpr.56.1.4&amp;rft_id=info%3Apmid%2F15001665&amp;rft.aulast=Brink&amp;rft.aufirst=C&amp;rft.au=Dahl%C3%A9n%2C+SE&amp;rft.au=Drazen%2C+J&amp;rft.au=Evans%2C+JF&amp;rft.au=Hay%2C+DW&amp;rft.au=Rovati%2C+GE&amp;rft.au=Serhan%2C+CN&amp;rft.au=Shimizu%2C+T&amp;rft.au=Yokomizo%2C+T&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3A5-oxo-eicosatetraenoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span>W</span>\n</li>\n<li id=\"cite_note-13\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-13\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Konya V, Bl\u00e4ttermann S, Jandl K, Platzer W, Ottersbach PA, Marsche G, G\u00fctschow M, Kostenis E, Heinemann A (May 2014). \"A biased non-G\u03b1i OXE-R antagonist demonstrates that G\u03b1i protein subunit is not directly involved in neutrophil, eosinophil, and monocyte activation by 5-oxo-ETE\". <i>Journal of Immunology</i>. <b>192</b> (10): 4774\u201382. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.4049/jimmunol.1302013\">10.4049/jimmunol.1302013</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/24733850\">24733850</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Immunology&amp;rft.atitle=A+biased+non-G%CE%B1i+OXE-R+antagonist+demonstrates+that+G%CE%B1i+protein+subunit+is+not+directly+involved+in+neutrophil%2C+eosinophil%2C+and+monocyte+activation+by+5-oxo-ETE&amp;rft.volume=192&amp;rft.issue=10&amp;rft.pages=4774-82&amp;rft.date=2014-05&amp;rft_id=info%3Adoi%2F10.4049%2Fjimmunol.1302013&amp;rft_id=info%3Apmid%2F24733850&amp;rft.aulast=Konya&amp;rft.aufirst=V&amp;rft.au=Bl%C3%A4ttermann%2C+S&amp;rft.au=Jandl%2C+K&amp;rft.au=Platzer%2C+W&amp;rft.au=Ottersbach%2C+PA&amp;rft.au=Marsche%2C+G&amp;rft.au=G%C3%BCtschow%2C+M&amp;rft.au=Kostenis%2C+E&amp;rft.au=Heinemann%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3A5-oxo-eicosatetraenoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-14\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-14\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Rossi, A. G.; O'Flaherty, J. T. (1991). \"Bioactions of 5-hydroxyicosatetraenoate and its interaction with platelet-activating factor\". <i>Lipids</i>. <b>26</b> (12): 1184\u20138. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/bf02536528\">10.1007/bf02536528</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/1668115\">1668115</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lipids&amp;rft.atitle=Bioactions+of+5-hydroxyicosatetraenoate+and+its+interaction+with+platelet-activating+factor&amp;rft.volume=26&amp;rft.issue=12&amp;rft.pages=1184-8&amp;rft.date=1991&amp;rft_id=info%3Adoi%2F10.1007%2Fbf02536528&amp;rft_id=info%3Apmid%2F1668115&amp;rft.aulast=Rossi&amp;rft.aufirst=A.+G.&amp;rft.au=O%27Flaherty%2C+J.+T.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3A5-oxo-eicosatetraenoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid23159987-15\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid23159987_15-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid23159987_15-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Cooke M, Di C\u00f3nsoli H, Maloberti P, Cornejo Maciel F (May 2013). \"Expression and function of OXE receptor, an eicosanoid receptor, in steroidogenic cells\". <i>Molecular and Cellular Endocrinology</i>. <b>371</b> (1\u20132): 71\u20138. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.mce.2012.11.003\">10.1016/j.mce.2012.11.003</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23159987\">23159987</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Molecular+and+Cellular+Endocrinology&amp;rft.atitle=Expression+and+function+of+OXE+receptor%2C+an+eicosanoid+receptor%2C+in+steroidogenic+cells&amp;rft.volume=371&amp;rft.issue=1%E2%80%932&amp;rft.pages=71-8&amp;rft.date=2013-05&amp;rft_id=info%3Adoi%2F10.1016%2Fj.mce.2012.11.003&amp;rft_id=info%3Apmid%2F23159987&amp;rft.aulast=Cooke&amp;rft.aufirst=M&amp;rft.au=Di+C%C3%B3nsoli%2C+H&amp;rft.au=Maloberti%2C+P&amp;rft.au=Cornejo+Maciel%2C+F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3A5-oxo-eicosatetraenoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Biochim._Biophys_2005-16\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Biochim._Biophys_2005_16-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Biochim._Biophys_2005_16-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Biochim._Biophys_2005_16-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">O'Flaherty JT, Rogers LC, Paumi CM, Hantgan RR, Thomas LR, Clay CE, High K, Chen YQ, Willingham MC, Smitherman PK, Kute TE, Rao A, Cramer SD, Morrow CS (October 2005). \"5-Oxo-ETE analogs and the proliferation of cancer cells\". <i>Biochimica et Biophysica Acta</i>. <b>1736</b> (3): 228\u201336. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.bbalip.2005.08.009\">10.1016/j.bbalip.2005.08.009</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16154383\">16154383</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biochimica+et+Biophysica+Acta&amp;rft.atitle=5-Oxo-ETE+analogs+and+the+proliferation+of+cancer+cells&amp;rft.volume=1736&amp;rft.issue=3&amp;rft.pages=228-36&amp;rft.date=2005-10&amp;rft_id=info%3Adoi%2F10.1016%2Fj.bbalip.2005.08.009&amp;rft_id=info%3Apmid%2F16154383&amp;rft.aulast=O%27Flaherty&amp;rft.aufirst=JT&amp;rft.au=Rogers%2C+LC&amp;rft.au=Paumi%2C+CM&amp;rft.au=Hantgan%2C+RR&amp;rft.au=Thomas%2C+LR&amp;rft.au=Clay%2C+CE&amp;rft.au=High%2C+K&amp;rft.au=Chen%2C+YQ&amp;rft.au=Willingham%2C+MC&amp;rft.au=Smitherman%2C+PK&amp;rft.au=Kute%2C+TE&amp;rft.au=Rao%2C+A&amp;rft.au=Cramer%2C+SD&amp;rft.au=Morrow%2C+CS&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3A5-oxo-eicosatetraenoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid17499751-17\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid17499751_17-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Morin C, Sirois M, Echave V, Gomes MM, Rousseau E (June 2007). \"Relaxing effects of 5-oxo-ETE on human bronchi involve BK Ca channel activation\". <i>Prostaglandins &amp; Other Lipid Mediators</i>. <b>83</b> (4): 311\u20139. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.prostaglandins.2007.03.001\">10.1016/j.prostaglandins.2007.03.001</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17499751\">17499751</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Prostaglandins+%26+Other+Lipid+Mediators&amp;rft.atitle=Relaxing+effects+of+5-oxo-ETE+on+human+bronchi+involve+BK+Ca+channel+activation&amp;rft.volume=83&amp;rft.issue=4&amp;rft.pages=311-9&amp;rft.date=2007-06&amp;rft_id=info%3Adoi%2F10.1016%2Fj.prostaglandins.2007.03.001&amp;rft_id=info%3Apmid%2F17499751&amp;rft.aulast=Morin&amp;rft.aufirst=C&amp;rft.au=Sirois%2C+M&amp;rft.au=Echave%2C+V&amp;rft.au=Gomes%2C+MM&amp;rft.au=Rousseau%2C+E&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3A5-oxo-eicosatetraenoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid8906847-18\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid8906847_18-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid8906847_18-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sozzani S, Zhou D, Locati M, Bernasconi S, Luini W, Mantovani A, O'Flaherty JT (November 1996). \"Stimulating properties of 5-oxo-eicosanoids for human monocytes: synergism with monocyte chemotactic protein-1 and -3\". <i>Journal of Immunology</i>. <b>157</b> (10): 4664\u201371. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/8906847\">8906847</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Immunology&amp;rft.atitle=Stimulating+properties+of+5-oxo-eicosanoids+for+human+monocytes%3A+synergism+with+monocyte+chemotactic+protein-1+and+-3&amp;rft.volume=157&amp;rft.issue=10&amp;rft.pages=4664-71&amp;rft.date=1996-11&amp;rft_id=info%3Apmid%2F8906847&amp;rft.aulast=Sozzani&amp;rft.aufirst=S&amp;rft.au=Zhou%2C+D&amp;rft.au=Locati%2C+M&amp;rft.au=Bernasconi%2C+S&amp;rft.au=Luini%2C+W&amp;rft.au=Mantovani%2C+A&amp;rft.au=O%27Flaherty%2C+JT&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3A5-oxo-eicosatetraenoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-19\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-19\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Muro S, Hamid Q, Olivenstein R, Taha R, Rokach J, Powell WS (October 2003). \"5-oxo-6,8,11,14-eicosatetraenoic acid induces the infiltration of granulocytes into human skin\". <i>The Journal of Allergy and Clinical Immunology</i>. <b>112</b> (4): 768\u201374. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0091-6749%2803%2901888-8\">10.1016/S0091-6749(03)01888-8</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/14564360\">14564360</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Allergy+and+Clinical+Immunology&amp;rft.atitle=5-oxo-6%2C8%2C11%2C14-eicosatetraenoic+acid+induces+the+infiltration+of+granulocytes+into+human+skin&amp;rft.volume=112&amp;rft.issue=4&amp;rft.pages=768-74&amp;rft.date=2003-10&amp;rft_id=info%3Adoi%2F10.1016%2FS0091-6749%2803%2901888-8&amp;rft_id=info%3Apmid%2F14564360&amp;rft.aulast=Muro&amp;rft.aufirst=S&amp;rft.au=Hamid%2C+Q&amp;rft.au=Olivenstein%2C+R&amp;rft.au=Taha%2C+R&amp;rft.au=Rokach%2C+J&amp;rft.au=Powell%2C+WS&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3A5-oxo-eicosatetraenoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-20\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-20\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Morin, C; Sirois, M; Echave, V; Gomes, M. M.; Rousseau, E (2007). \"Relaxing effects of 5-oxo-ETE on human bronchi involve BK Ca channel activation\". <i>Prostaglandins &amp; Other Lipid Mediators</i>. <b>83</b> (4): 311\u20139. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.prostaglandins.2007.03.001\">10.1016/j.prostaglandins.2007.03.001</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17499751\">17499751</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Prostaglandins+%26+Other+Lipid+Mediators&amp;rft.atitle=Relaxing+effects+of+5-oxo-ETE+on+human+bronchi+involve+BK+Ca+channel+activation&amp;rft.volume=83&amp;rft.issue=4&amp;rft.pages=311-9&amp;rft.date=2007&amp;rft_id=info%3Adoi%2F10.1016%2Fj.prostaglandins.2007.03.001&amp;rft_id=info%3Apmid%2F17499751&amp;rft.aulast=Morin&amp;rft.aufirst=C&amp;rft.au=Sirois%2C+M&amp;rft.au=Echave%2C+V&amp;rft.au=Gomes%2C+M.+M.&amp;rft.au=Rousseau%2C+E&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3A5-oxo-eicosatetraenoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-21\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-21\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Grant GE, Rubino S, Gravel S, Wang X, Patel P, Rokach J, Powell WS (June 2011). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3146358\">\"Enhanced formation of 5-oxo-6,8,11,14-eicosatetraenoic acid by cancer cells in response to oxidative stress, docosahexaenoic acid and neutrophil-derived 5-hydroxy-6,8,11,14-eicosatetraenoic acid\"</a>. <i>Carcinogenesis</i>. <b>32</b> (6): 822\u20138. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1093/carcin/bgr044\">10.1093/carcin/bgr044</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3146358\">3146358</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21393477\">21393477</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Carcinogenesis&amp;rft.atitle=Enhanced+formation+of+5-oxo-6%2C8%2C11%2C14-eicosatetraenoic+acid+by+cancer+cells+in+response+to+oxidative+stress%2C+docosahexaenoic+acid+and+neutrophil-derived+5-hydroxy-6%2C8%2C11%2C14-eicosatetraenoic+acid&amp;rft.volume=32&amp;rft.issue=6&amp;rft.pages=822-8&amp;rft.date=2011-06&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3146358&amp;rft_id=info%3Apmid%2F21393477&amp;rft_id=info%3Adoi%2F10.1093%2Fcarcin%2Fbgr044&amp;rft.aulast=Grant&amp;rft.aufirst=GE&amp;rft.au=Rubino%2C+S&amp;rft.au=Gravel%2C+S&amp;rft.au=Wang%2C+X&amp;rft.au=Patel%2C+P&amp;rft.au=Rokach%2C+J&amp;rft.au=Powell%2C+WS&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3146358&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3A5-oxo-eicosatetraenoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-22\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-22\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">MacLeod RJ, Lembessis P, Hamilton JR, Powell WS (November 1999). \"5-Oxo-6,8,11,14-eicosatetraenoic acid stimulates isotonic volume reduction of guinea pig jejunal crypt epithelial cells\". <i>The Journal of Pharmacology and Experimental Therapeutics</i>. <b>291</b> (2): 511\u20136. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/10525065\">10525065</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Pharmacology+and+Experimental+Therapeutics&amp;rft.atitle=5-Oxo-6%2C8%2C11%2C14-eicosatetraenoic+acid+stimulates+isotonic+volume+reduction+of+guinea+pig+jejunal+crypt+epithelial+cells&amp;rft.volume=291&amp;rft.issue=2&amp;rft.pages=511-6&amp;rft.date=1999-11&amp;rft_id=info%3Apmid%2F10525065&amp;rft.aulast=MacLeod&amp;rft.aufirst=RJ&amp;rft.au=Lembessis%2C+P&amp;rft.au=Hamilton%2C+JR&amp;rft.au=Powell%2C+WS&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3A5-oxo-eicosatetraenoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid8683135-23\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid8683135_23-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid8683135_23-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">O'Flaherty JT, Kuroki M, Nixon AB, Wijkander J, Yee E, Lee SL, Smitherman PK, Wykle RL, Daniel LW (July 1996). \"5-Oxo-eicosatetraenoate is a broadly active, eosinophil-selective stimulus for human granulocytes\". <i>Journal of Immunology</i>. <b>157</b> (1): 336\u201342. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/8683135\">8683135</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Immunology&amp;rft.atitle=5-Oxo-eicosatetraenoate+is+a+broadly+active%2C+eosinophil-selective+stimulus+for+human+granulocytes&amp;rft.volume=157&amp;rft.issue=1&amp;rft.pages=336-42&amp;rft.date=1996-07&amp;rft_id=info%3Apmid%2F8683135&amp;rft.aulast=O%27Flaherty&amp;rft.aufirst=JT&amp;rft.au=Kuroki%2C+M&amp;rft.au=Nixon%2C+AB&amp;rft.au=Wijkander%2C+J&amp;rft.au=Yee%2C+E&amp;rft.au=Lee%2C+SL&amp;rft.au=Smitherman%2C+PK&amp;rft.au=Wykle%2C+RL&amp;rft.au=Daniel%2C+LW&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3A5-oxo-eicosatetraenoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid7803484-24\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid7803484_24-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid7803484_24-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">O'Flaherty JT, Cordes JF, Lee SL, Samuel M, Thomas MJ (December 1994). \"Chemical and biological characterization of oxo-eicosatetraenoic acids\". <i>Biochimica et Biophysica Acta</i>. <b>1201</b> (3): 505\u201315. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/0304-4165%2894%2990083-3\">10.1016/0304-4165(94)90083-3</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/7803484\">7803484</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biochimica+et+Biophysica+Acta&amp;rft.atitle=Chemical+and+biological+characterization+of+oxo-eicosatetraenoic+acids&amp;rft.volume=1201&amp;rft.issue=3&amp;rft.pages=505-15&amp;rft.date=1994-12&amp;rft_id=info%3Adoi%2F10.1016%2F0304-4165%2894%2990083-3&amp;rft_id=info%3Apmid%2F7803484&amp;rft.aulast=O%27Flaherty&amp;rft.aufirst=JT&amp;rft.au=Cordes%2C+JF&amp;rft.au=Lee%2C+SL&amp;rft.au=Samuel%2C+M&amp;rft.au=Thomas%2C+MJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3A5-oxo-eicosatetraenoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-25\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-25\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">O'Flaherty JT, Kuroki M, Nixon AB, Wijkander J, Yee E, Lee SL, Smitherman PK, Wykle RL, Daniel LW (July 1996). \"5-Oxo-eicosanoids and hematopoietic cytokines cooperate in stimulating neutrophil function and the mitogen-activated protein kinase pathway\". <i>The Journal of Biological Chemistry</i>. <b>271</b> (30): 17821\u20138. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1074/jbc.271.30.17821\">10.1074/jbc.271.30.17821</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/8663432\">8663432</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Biological+Chemistry&amp;rft.atitle=5-Oxo-eicosanoids+and+hematopoietic+cytokines+cooperate+in+stimulating+neutrophil+function+and+the+mitogen-activated+protein+kinase+pathway&amp;rft.volume=271&amp;rft.issue=30&amp;rft.pages=17821-8&amp;rft.date=1996-07&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.271.30.17821&amp;rft_id=info%3Apmid%2F8663432&amp;rft.aulast=O%27Flaherty&amp;rft.aufirst=JT&amp;rft.au=Kuroki%2C+M&amp;rft.au=Nixon%2C+AB&amp;rft.au=Wijkander%2C+J&amp;rft.au=Yee%2C+E&amp;rft.au=Lee%2C+SL&amp;rft.au=Smitherman%2C+PK&amp;rft.au=Wykle%2C+RL&amp;rft.au=Daniel%2C+LW&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3A5-oxo-eicosatetraenoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-26\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-26\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">O'Flaherty JT, Cordes JF (June 1994). \"Human neutrophil degranulation responses to nucleotides\". <i>Laboratory Investigation; A Journal of Technical Methods and Pathology</i>. <b>70</b> (6): 816\u201321. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/8015286\">8015286</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Laboratory+Investigation%3B+A+Journal+of+Technical+Methods+and+Pathology&amp;rft.atitle=Human+neutrophil+degranulation+responses+to+nucleotides&amp;rft.volume=70&amp;rft.issue=6&amp;rft.pages=816-21&amp;rft.date=1994-06&amp;rft_id=info%3Apmid%2F8015286&amp;rft.aulast=O%27Flaherty&amp;rft.aufirst=JT&amp;rft.au=Cordes%2C+JF&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3A5-oxo-eicosatetraenoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-27\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-27\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Guilbert M, Ferland C, Boss\u00e9 M, Flamand N, Lavigne S, Laviolette M (July 1999). \"5-Oxo-6,8,11,14-eicosatetraenoic acid induces important eosinophil transmigration through basement membrane components: comparison of normal and asthmatic eosinophils\". <i>American Journal of Respiratory Cell and Molecular Biology</i>. <b>21</b> (1): 97\u2013104. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1165/ajrcmb.21.1.3517\">10.1165/ajrcmb.21.1.3517</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/10385597\">10385597</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=American+Journal+of+Respiratory+Cell+and+Molecular+Biology&amp;rft.atitle=5-Oxo-6%2C8%2C11%2C14-eicosatetraenoic+acid+induces+important+eosinophil+transmigration+through+basement+membrane+components%3A+comparison+of+normal+and+asthmatic+eosinophils&amp;rft.volume=21&amp;rft.issue=1&amp;rft.pages=97-104&amp;rft.date=1999-07&amp;rft_id=info%3Adoi%2F10.1165%2Fajrcmb.21.1.3517&amp;rft_id=info%3Apmid%2F10385597&amp;rft.aulast=Guilbert&amp;rft.aufirst=M&amp;rft.au=Ferland%2C+C&amp;rft.au=Boss%C3%A9%2C+M&amp;rft.au=Flamand%2C+N&amp;rft.au=Lavigne%2C+S&amp;rft.au=Laviolette%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3A5-oxo-eicosatetraenoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div>\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"Eicosanoids\" style=\"padding:3px\"><table class=\"nowraplinks hlist collapsible autocollapse navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Eicosanoids\" title=\"Template:Eicosanoids\"><abbr title=\"View this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Eicosanoids\" title=\"Template talk:Eicosanoids\"><abbr title=\"Discuss this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Template:Eicosanoids&amp;action=edit\"><abbr title=\"Edit this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">e</abbr></a></li></ul></div><div id=\"Eicosanoids\" style=\"font-size:114%;margin:0 4em\"><a href=\"/wiki/Eicosanoid\" title=\"Eicosanoid\">Eicosanoids</a></div></th></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Precursor</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Arachidonic_acid\" title=\"Arachidonic acid\">Arachidonic acid</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Prostanoid\" title=\"Prostanoid\">Prostanoids</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Prostaglandin\" title=\"Prostaglandin\">Prostaglandins</a> (PG)</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Precursor</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Prostaglandin_H2\" title=\"Prostaglandin H2\">H<sub>2</sub></a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Active</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">D/J</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Prostaglandin_D2\" title=\"Prostaglandin D2\">D<sub>2</sub></a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Prostaglandin_E\" title=\"Prostaglandin E\">E</a>/F</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Prostaglandin_E2\" title=\"Prostaglandin E2\">E<sub>2</sub> (Dinoprostone)</a></li></ul>\n<ul><li><a href=\"/wiki/Prostaglandin_E1\" title=\"Prostaglandin E1\">E<sub>1</sub> (Alprostadil)</a></li></ul>\n<ul><li><a href=\"/wiki/Prostaglandin_F2alpha\" title=\"Prostaglandin F2alpha\">F<sub>2\u03b1</sub> (Dinoprost)</a>:</li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">I</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Prostacyclin\" title=\"Prostacyclin\">I<sub>2</sub> (Prostacyclin/Epoprostenol)</a>:</li></ul>\n</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Thromboxane\" title=\"Thromboxane\">Thromboxanes</a> (TX)</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Thromboxane_A2\" title=\"Thromboxane A2\">A<sub>2</sub></a></li>\n<li><a href=\"/wiki/Thromboxane_B2\" title=\"Thromboxane B2\">B<sub>2</sub></a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Leukotriene\" title=\"Leukotriene\">Leukotrienes</a> (LT)</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Precursor</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Arachidonic_acid_5-hydroperoxide\" title=\"Arachidonic acid 5-hydroperoxide\">Arachidonic acid 5-hydroperoxide</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Initial</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Leukotriene_A4\" title=\"Leukotriene A4\">A<sub>4</sub></a></li>\n<li><a href=\"/wiki/Leukotriene_B4\" title=\"Leukotriene B4\">B<sub>4</sub></a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Slow-reacting_substance_of_anaphylaxis\" title=\"Slow-reacting substance of anaphylaxis\">SRS-A</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Leukotriene_C4\" title=\"Leukotriene C4\">C<sub>4</sub></a></li>\n<li><a href=\"/wiki/Leukotriene_D4\" title=\"Leukotriene D4\">D<sub>4</sub></a></li>\n<li><a href=\"/wiki/Leukotriene_E4\" title=\"Leukotriene E4\">E<sub>4</sub></a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Eoxin\" title=\"Eoxin\">Eoxins</a> (EX)</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Precursor</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/w/index.php?title=Arachidonic_acid_15-hydroperoxide&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Arachidonic acid 15-hydroperoxide (page does not exist)\">Arachidonic acid 15-hydroperoxide</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Eoxins</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Eoxin_A4\" title=\"Eoxin A4\">A<sub>4</sub></a></li>\n<li><a href=\"/wiki/Eoxin_C4\" title=\"Eoxin C4\">C<sub>4</sub></a></li>\n<li><a href=\"/wiki/Eoxin_D4\" title=\"Eoxin D4\">D<sub>4</sub></a></li>\n<li><a href=\"/wiki/Eoxin_E4\" title=\"Eoxin E4\">E<sub>4</sub></a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Nonclassic_eicosanoid\" title=\"Nonclassic eicosanoid\">Nonclassic</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Lipoxin\" title=\"Lipoxin\">Lipoxins</a> (LX) (<a href=\"/wiki/Lipoxin\" title=\"Lipoxin\">A<sub>4</sub></a>, <a href=\"/wiki/Lipoxin\" title=\"Lipoxin\">B<sub>4</sub></a>)</li>\n<li><a href=\"/wiki/Virodhamine\" title=\"Virodhamine\">Virodhamine</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">By function</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><i><a href=\"/wiki/Bronchoconstriction\" title=\"Bronchoconstriction\">bronchoconstriction</a></i>\n<ul><li><a href=\"/wiki/Prostaglandin_D2\" title=\"Prostaglandin D2\">PGD<sub>2</sub></a></li>\n<li><a href=\"/wiki/Thromboxane_A2\" title=\"Thromboxane A2\">TXA<sub>2</sub></a></li>\n<li><a href=\"/wiki/Leukotriene_C4\" title=\"Leukotriene C4\">LTC<sub>4</sub></a></li>\n<li><a href=\"/wiki/Leukotriene_D4\" title=\"Leukotriene D4\">LTD<sub>4</sub></a></li>\n<li><a href=\"/wiki/Leukotriene_E4\" title=\"Leukotriene E4\">LTE<sub>4</sub></a></li></ul></li></ul>\n<ul><li><i><a href=\"/wiki/Vasoconstriction\" title=\"Vasoconstriction\">vasoconstriction</a></i>\n<ul><li><a href=\"/wiki/Prostaglandin_F2alpha\" title=\"Prostaglandin F2alpha\">PGF<sub>2\u03b1</sub></a></li>\n<li><a href=\"/wiki/Thromboxane_A2\" title=\"Thromboxane A2\">TXA<sub>2</sub></a></li>\n<li><a href=\"/wiki/Thromboxane_B2\" title=\"Thromboxane B2\">TXB<sub>2</sub></a>)</li></ul></li>\n<li><i><a href=\"/wiki/Vasodilation\" title=\"Vasodilation\">vasodilation</a></i>\n<ul><li><a href=\"/wiki/Prostaglandin_E2\" title=\"Prostaglandin E2\">PGE<sub>2</sub></a></li>\n<li><a href=\"/wiki/Prostacyclin\" title=\"Prostacyclin\">PGI<sub>2</sub></a></li>\n<li><a href=\"/wiki/Leukotriene_C4\" title=\"Leukotriene C4\">LTC<sub>4</sub></a></li>\n<li><a href=\"/wiki/Leukotriene_D4\" title=\"Leukotriene D4\">LTD<sub>4</sub></a></li>\n<li><a href=\"/wiki/Leukotriene_E4\" title=\"Leukotriene E4\">LTE<sub>4</sub></a></li></ul></li></ul>\n<ul><li><i><a href=\"/wiki/Platelet\" title=\"Platelet\">platelets</a>: induce</i>\n<ul><li><a href=\"/wiki/Thromboxane_A2\" title=\"Thromboxane A2\">TXA<sub>2</sub></a></li></ul></li>\n<li><i>inhibit</i>\n<ul><li><a href=\"/wiki/Prostaglandin_D2\" title=\"Prostaglandin D2\">PGD<sub>2</sub></a></li>\n<li><a href=\"/wiki/Prostacyclin\" title=\"Prostacyclin\">PGI<sub>2</sub></a></li></ul></li>\n<li><i><a href=\"/wiki/Leukocyte\" class=\"mw-redirect\" title=\"Leukocyte\">leukocytes</a>: induce</i>\n<ul><li><a href=\"/wiki/Thromboxane_A2\" title=\"Thromboxane A2\">TXA<sub>2</sub></a></li>\n<li><a href=\"/wiki/Leukotriene_B4\" title=\"Leukotriene B4\">LTB<sub>4</sub></a></li></ul></li>\n<li><i>inhibit</i>\n<ul><li><a href=\"/wiki/Prostaglandin_D2\" title=\"Prostaglandin D2\">PGD<sub>2</sub></a></li>\n<li><a href=\"/wiki/Prostaglandin_E2\" title=\"Prostaglandin E2\">PGE<sub>2</sub></a></li></ul></li></ul>\n<ul><li><i><a href=\"/wiki/Fever\" title=\"Fever\">fever</a> stimulation:</i>\n<ul><li><a href=\"/wiki/Prostaglandin_E2\" title=\"Prostaglandin E2\">PGE<sub>2</sub></a></li></ul></li></ul>\n<ul><li><i><a href=\"/wiki/Childbirth\" title=\"Childbirth\">labor</a> stimulation:</i>\n<ul><li><a href=\"/wiki/Prostaglandin_E2\" title=\"Prostaglandin E2\">PGE<sub>2</sub></a> (Dinoprostone)</li>\n<li><a href=\"/wiki/Prostaglandin_F2alpha\" title=\"Prostaglandin F2alpha\">PGF<sub>2\u03b1</sub></a> (Dinoprost)</li></ul></li></ul>\n</div></td></tr></tbody></table></div>\n\n<!-- \nNewPP limit report\nParsed by mw2183\nCached time: 20180922003653\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.704 seconds\nReal time usage: 0.825 seconds\nPreprocessor visited node count: 5496/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 144227/2097152 bytes\nTemplate argument size: 11461/2097152 bytes\nHighest expansion depth: 16/40\nExpensive parser function count: 1/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 52359/5000000 bytes\nNumber of Wikibase entities loaded: 1/400\nLua time usage: 0.302/10.000 seconds\nLua memory usage: 4.55 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  670.184      1 -total\n 52.60%  352.508      1 Template:Chembox\n 38.50%  257.994      1 Template:Reflist\n 31.06%  208.167     27 Template:Cite_journal\n 29.94%  200.635      1 Template:Chembox_Identifiers\n 16.83%  112.791      3 Template:Chembox_headerbar\n 16.37%  109.692      9 Template:Trim\n 13.24%   88.757      1 Template:Chembox_Properties\n  7.28%   48.795      5 Template:Main_other\n  6.95%   46.567     10 Template:Unbulleted_list\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:47891463-0!canonical!math=5 and timestamp 20180922003653 and revision id 844577417\n -->\n</div>"},"langlinks":[],"categories":[{"sortkey":"5-oxo-ETE, 5-oxoETE, 5-oxoeicosatetraenoic acid","hidden":"","*":"Articles_without_InChI_source"},{"sortkey":"5-oxo-ETE, 5-oxoETE, 5-oxoeicosatetraenoic acid","hidden":"","*":"Articles_without_UNII_source"},{"sortkey":"5-oxo-ETE, 5-oxoETE, 5-oxoeicosatetraenoic acid","hidden":"","*":"Articles_containing_unverified_chemical_infoboxes"},{"sortkey":"5-oxo-ETE, 5-oxoETE, 5-oxoeicosatetraenoic acid","*":"Metabolic_pathways"},{"sortkey":"5-oxo-ETE, 5-oxoETE, 5-oxoeicosatetraenoic acid","*":"Fatty_acids"},{"sortkey":"5-oxo-ETE, 5-oxoETE, 5-oxoeicosatetraenoic acid","*":"Eicosanoids"},{"sortkey":"5-oxo-ETE, 5-oxoETE, 5-oxoeicosatetraenoic acid","*":"Immunology"},{"sortkey":"5-oxo-ETE, 5-oxoETE, 5-oxoeicosatetraenoic acid","*":"Allergology"},{"sortkey":"5-oxo-ETE, 5-oxoETE, 5-oxoeicosatetraenoic acid","*":"Inflammations"},{"sortkey":"5-oxo-ETE, 5-oxoETE, 5-oxoeicosatetraenoic acid","*":"Human_physiology"},{"sortkey":"5-oxo-ETE, 5-oxoETE, 5-oxoeicosatetraenoic acid","*":"Animal_physiology"}],"links":[{"ns":0,"*":"5-oxo-eicosatetraenoic acid (data page)"},{"ns":0,"exists":"","*":"12-lipoxygenase"},{"ns":0,"exists":"","*":"5-HETE"},{"ns":0,"exists":"","*":"5-Hydroxyeicosanoid dehydrogenase"},{"ns":0,"exists":"","*":"ALOX15"},{"ns":0,"exists":"","*":"Adenosine triphosphate"},{"ns":0,"exists":"","*":"Akt"},{"ns":0,"exists":"","*":"Aldosterone"},{"ns":0,"exists":"","*":"Apoptosis"},{"ns":0,"exists":"","*":"Arachidonate 15-lipoxygenase"},{"ns":0,"exists":"","*":"Arachidonate 15-lipoxygenase-2"},{"ns":0,"exists":"","*":"Arachidonate 5-lipoxygenase"},{"ns":0,"exists":"","*":"Arachidonic acid"},{"ns":0,"exists":"","*":"Arachidonic acid 5-hydroperoxide"},{"ns":0,"exists":"","*":"Asthma"},{"ns":0,"exists":"","*":"Autocrine signaling"},{"ns":0,"exists":"","*":"B-lymphocyte"},{"ns":0,"exists":"","*":"B-lymphocytes"},{"ns":0,"exists":"","*":"Basophil"},{"ns":0,"exists":"","*":"Bronchoconstriction"},{"ns":0,"exists":"","*":"CAS Registry Number"},{"ns":0,"exists":"","*":"CCL2"},{"ns":0,"exists":"","*":"CCL8"},{"ns":0,"exists":"","*":"CYP1A1"},{"ns":0,"exists":"","*":"CYP1A2"},{"ns":0,"exists":"","*":"CYP1B1"},{"ns":0,"exists":"","*":"CYP2S1"},{"ns":0,"exists":"","*":"Cell signaling"},{"ns":0,"exists":"","*":"ChEBI"},{"ns":0,"exists":"","*":"ChEMBL"},{"ns":0,"exists":"","*":"ChemSpider"},{"ns":0,"exists":"","*":"Chemical formula"},{"ns":0,"exists":"","*":"Chemical nomenclature"},{"ns":0,"exists":"","*":"Chemokines"},{"ns":0,"exists":"","*":"Chemotaxis"},{"ns":0,"exists":"","*":"Childbirth"},{"ns":0,"exists":"","*":"Complement component 5a"},{"ns":0,"exists":"","*":"Cytochrome P450"},{"ns":0,"exists":"","*":"Cytokine"},{"ns":0,"exists":"","*":"Degranulation"},{"ns":0,"exists":"","*":"Dendritic cell"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Eicosanoid"},{"ns":0,"exists":"","*":"Endothelial cell"},{"ns":0,"exists":"","*":"Eosinophil"},{"ns":0,"exists":"","*":"Eosinophils"},{"ns":0,"exists":"","*":"Eoxin"},{"ns":0,"exists":"","*":"Eoxin A4"},{"ns":0,"exists":"","*":"Eoxin C4"},{"ns":0,"exists":"","*":"Eoxin D4"},{"ns":0,"exists":"","*":"Eoxin E4"},{"ns":0,"exists":"","*":"Epithelial cell"},{"ns":0,"exists":"","*":"Ester"},{"ns":0,"exists":"","*":"FMLP"},{"ns":0,"exists":"","*":"Fever"},{"ns":0,"exists":"","*":"GPR109A"},{"ns":0,"exists":"","*":"GPR109B"},{"ns":0,"exists":"","*":"GPR81"},{"ns":0,"exists":"","*":"G beta-gamma complex"},{"ns":0,"exists":"","*":"G protein"},{"ns":0,"exists":"","*":"G protein-coupled receptor"},{"ns":0,"exists":"","*":"Gi alpha subunit"},{"ns":0,"exists":"","*":"Glycerolipid"},{"ns":0,"exists":"","*":"Granulocyte-macrophage colony stimulating factor"},{"ns":0,"exists":"","*":"Granulocyte colony-stimulating factor"},{"ns":0,"exists":"","*":"H295R"},{"ns":0,"exists":"","*":"Heme"},{"ns":0,"exists":"","*":"Inflammation"},{"ns":0,"exists":"","*":"Interleukin 5"},{"ns":0,"exists":"","*":"International Chemical Identifier"},{"ns":0,"exists":"","*":"JSmol"},{"ns":0,"exists":"","*":"KEGG"},{"ns":0,"exists":"","*":"Keratinocytes"},{"ns":0,"exists":"","*":"Kilodalton"},{"ns":0,"exists":"","*":"LTB4"},{"ns":0,"exists":"","*":"Leukocyte"},{"ns":0,"exists":"","*":"Leukocytes"},{"ns":0,"exists":"","*":"Leukotriene"},{"ns":0,"exists":"","*":"Leukotriene A4"},{"ns":0,"exists":"","*":"Leukotriene B4"},{"ns":0,"exists":"","*":"Leukotriene C4"},{"ns":0,"exists":"","*":"Leukotriene D4"},{"ns":0,"exists":"","*":"Leukotriene E4"},{"ns":0,"exists":"","*":"Lipoxin"},{"ns":0,"exists":"","*":"MAPK/ERK"},{"ns":0,"exists":"","*":"MRNA"},{"ns":0,"exists":"","*":"Macrophage"},{"ns":0,"exists":"","*":"Macrophages"},{"ns":0,"exists":"","*":"Microsome"},{"ns":0,"exists":"","*":"Molar mass"},{"ns":0,"exists":"","*":"Monocyte"},{"ns":0,"exists":"","*":"Neutrophil"},{"ns":0,"exists":"","*":"Neutrophils"},{"ns":0,"exists":"","*":"Niacin"},{"ns":0,"exists":"","*":"Niacin receptor 1"},{"ns":0,"exists":"","*":"Nicotinamide adenine dinucleotide phosphate"},{"ns":0,"exists":"","*":"Nonclassic eicosanoid"},{"ns":0,"exists":"","*":"Nucleotides"},{"ns":0,"exists":"","*":"OXER1"},{"ns":0,"exists":"","*":"Ortholog"},{"ns":0,"exists":"","*":"Oxidative stress"},{"ns":0,"exists":"","*":"Oxoeicosanoid receptor 1"},{"ns":0,"exists":"","*":"Oxygen radicals"},{"ns":0,"exists":"","*":"P38 mitogen-activated protein kinases"},{"ns":0,"exists":"","*":"PC-3"},{"ns":0,"exists":"","*":"PI3K"},{"ns":0,"exists":"","*":"Paracrine signaling"},{"ns":0,"exists":"","*":"Peroxides"},{"ns":0,"exists":"","*":"Peroxisome proliferator-activated receptor gamma"},{"ns":0,"exists":"","*":"Pertussis toxin"},{"ns":0,"exists":"","*":"Phagocytes"},{"ns":0,"exists":"","*":"Phospholipase A2"},{"ns":0,"exists":"","*":"Phospholipid"},{"ns":0,"exists":"","*":"Phospholipids"},{"ns":0,"exists":"","*":"Plasma membrane"},{"ns":0,"exists":"","*":"Platelet"},{"ns":0,"exists":"","*":"Platelet-activating factor"},{"ns":0,"exists":"","*":"Platelets"},{"ns":0,"exists":"","*":"Pre-clinical development"},{"ns":0,"exists":"","*":"Progesterone"},{"ns":0,"exists":"","*":"Prostacyclin"},{"ns":0,"exists":"","*":"Prostaglandin"},{"ns":0,"exists":"","*":"Prostaglandin D2"},{"ns":0,"exists":"","*":"Prostaglandin E"},{"ns":0,"exists":"","*":"Prostaglandin E1"},{"ns":0,"exists":"","*":"Prostaglandin E2"},{"ns":0,"exists":"","*":"Prostaglandin F2alpha"},{"ns":0,"exists":"","*":"Prostaglandin H2"},{"ns":0,"exists":"","*":"Prostanoid"},{"ns":0,"exists":"","*":"Protein kinase C"},{"ns":0,"exists":"","*":"PubChem"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Reactive oxygen species"},{"ns":0,"exists":"","*":"Simplified molecular-input line-entry system"},{"ns":0,"exists":"","*":"Slow-reacting substance of anaphylaxis"},{"ns":0,"exists":"","*":"Smooth muscle cell"},{"ns":0,"exists":"","*":"Standard state"},{"ns":0,"exists":"","*":"Stereoisomer"},{"ns":0,"exists":"","*":"Superoxide"},{"ns":0,"exists":"","*":"Synergy"},{"ns":0,"exists":"","*":"Thromboxane"},{"ns":0,"exists":"","*":"Thromboxane A2"},{"ns":0,"exists":"","*":"Thromboxane B2"},{"ns":0,"exists":"","*":"Translation studies"},{"ns":0,"exists":"","*":"Tumor necrosis factor \u03b1"},{"ns":0,"exists":"","*":"Vasoconstriction"},{"ns":0,"exists":"","*":"Vasodilation"},{"ns":0,"exists":"","*":"Virodhamine"},{"ns":0,"*":"Arachidonic acid 15-hydroperoxide"},{"ns":10,"exists":"","*":"Template:Eicosanoids"},{"ns":4,"exists":"","*":"Wikipedia:Chemical infobox"},{"ns":11,"exists":"","*":"Template talk:Eicosanoids"}],"templates":[{"ns":10,"exists":"","*":"Template:Chembox"},{"ns":10,"exists":"","*":"Template:Chembox image"},{"ns":10,"exists":"","*":"Template:Chembox image cell"},{"ns":10,"exists":"","*":"Template:Chembox image sbs"},{"ns":10,"exists":"","*":"Template:Chembox AllOtherNames"},{"ns":10,"exists":"","*":"Template:Chembox headerbar"},{"ns":10,"exists":"","*":"Template:Trim"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:Chembox AllOtherNames/format"},{"ns":10,"exists":"","*":"Template:Chembox Identifiers"},{"ns":10,"exists":"","*":"Template:Chembox parametercheck"},{"ns":10,"exists":"","*":"Template:Chembox templatePar/formatPreviewMessage"},{"ns":10,"exists":"","*":"Template:Button"},{"ns":10,"exists":"","*":"Template:Border-radius"},{"ns":10,"exists":"","*":"Template:Linear-gradient"},{"ns":10,"exists":"","*":"Template:Chembox Indexlist"},{"ns":10,"exists":"","*":"Template:Chembox CASNo"},{"ns":10,"exists":"","*":"Template:Unbulleted list"},{"ns":10,"exists":"","*":"Template:Chembox CASNo/format"},{"ns":10,"exists":"","*":"Template:Longitem"},{"ns":10,"exists":"","*":"Template:Chembox Jmol"},{"ns":10,"exists":"","*":"Template:Chembox Jmol/format"},{"ns":10,"exists":"","*":"Template:Chembox ChEBI"},{"ns":10,"exists":"","*":"Template:Chembox ChEBI/format"},{"ns":10,"exists":"","*":"Template:Chembox ChEMBL"},{"ns":10,"exists":"","*":"Template:Chembox ChEMBL/format"},{"ns":10,"exists":"","*":"Template:Chembox ChemSpiderID"},{"ns":10,"exists":"","*":"Template:Chembox ChemSpiderID/format"},{"ns":10,"exists":"","*":"Template:Chembox DrugBank"},{"ns":10,"exists":"","*":"Template:Chembox DrugBank/format"},{"ns":10,"exists":"","*":"Template:Chembox IUPHAR ligand"},{"ns":10,"exists":"","*":"Template:Chembox IUPHAR ligand/format"},{"ns":10,"exists":"","*":"Template:Chembox KEGG"},{"ns":10,"exists":"","*":"Template:Chembox KEGG/format"},{"ns":10,"exists":"","*":"Template:Chembox PubChem"},{"ns":10,"exists":"","*":"Template:Chembox PubChem/format"},{"ns":10,"exists":"","*":"Template:Abbr"},{"ns":10,"exists":"","*":"Template:Chembox UNII"},{"ns":10,"exists":"","*":"Template:Chembox UNII/format"},{"ns":10,"exists":"","*":"Template:Chembox InChI"},{"ns":10,"exists":"","*":"Template:Collapsible list"},{"ns":10,"exists":"","*":"Template:Chembox InChI/format"},{"ns":10,"exists":"","*":"Template:Chembox SMILES"},{"ns":10,"exists":"","*":"Template:Chembox SMILES/format"},{"ns":10,"exists":"","*":"Template:Chembox Properties"},{"ns":10,"exists":"","*":"Template:Chembox Elements"},{"ns":10,"exists":"","*":"Template:Chembox Elements/molecular formula"},{"ns":10,"exists":"","*":"Template:Yesno"},{"ns":10,"exists":"","*":"Template:Chembox Footer"},{"ns":10,"exists":"","*":"Template:Chembox Footer/tracking"},{"ns":10,"exists":"","*":"Template:ParmPart"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Column-width"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Eicosanoids"},{"ns":10,"exists":"","*":"Template:Navbox"},{"ns":828,"exists":"","*":"Module:InfoboxImage"},{"ns":828,"exists":"","*":"Module:String"},{"ns":828,"exists":"","*":"Module:Math"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:ParameterCount"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Wikidata"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:I18n"},{"ns":828,"*":"Module:Math/i18n"},{"ns":828,"exists":"","*":"Module:TemplatePar"},{"ns":828,"exists":"","*":"Module:List"},{"ns":828,"exists":"","*":"Module:TableTools"},{"ns":828,"exists":"","*":"Module:Wikidata/i18n"},{"ns":828,"exists":"","*":"Module:Collapsible list"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"},{"ns":828,"exists":"","*":"Module:Navbox"},{"ns":828,"exists":"","*":"Module:Navbar"}],"images":["Lock-green.svg","5-oxo-ETE.svg"],"externallinks":["//doi.org/10.1016/j.bbalip.2014.10.008","//www.ncbi.nlm.nih.gov/pubmed/25449650","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4830392","//doi.org/10.1016/j.bcp.2015.05.009","//www.ncbi.nlm.nih.gov/pubmed/26032638","//www.ncbi.nlm.nih.gov/pmc/articles/PMC5710732","//doi.org/10.1016/j.plipres.2013.09.001","//www.ncbi.nlm.nih.gov/pubmed/24056189","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3033693","//doi.org/10.1124/dmd.110.035121","//www.ncbi.nlm.nih.gov/pubmed/21068195","//doi.org/10.1074/jbc.M208496200","//www.ncbi.nlm.nih.gov/pubmed/12547823","//doi.org/10.1016/s1388-1981(99)00198-5","//www.ncbi.nlm.nih.gov/pubmed/10685030","//doi.org/10.1007/s000110050641","//www.ncbi.nlm.nih.gov/pubmed/11131304","//doi.org/10.1074/jbc.273.49.32535","//www.ncbi.nlm.nih.gov/pubmed/9829988","//www.ncbi.nlm.nih.gov/pubmed/11160610","//doi.org/10.1016/s0090-6980(02)00049-7","//www.ncbi.nlm.nih.gov/pubmed/12432937","//doi.org/10.1124/pr.56.1.4","//www.ncbi.nlm.nih.gov/pubmed/15001665","//doi.org/10.4049/jimmunol.1302013","//www.ncbi.nlm.nih.gov/pubmed/24733850","//doi.org/10.1007/bf02536528","//www.ncbi.nlm.nih.gov/pubmed/1668115","//doi.org/10.1016/j.mce.2012.11.003","//www.ncbi.nlm.nih.gov/pubmed/23159987","//doi.org/10.1016/j.bbalip.2005.08.009","//www.ncbi.nlm.nih.gov/pubmed/16154383","//doi.org/10.1016/j.prostaglandins.2007.03.001","//www.ncbi.nlm.nih.gov/pubmed/17499751","//www.ncbi.nlm.nih.gov/pubmed/8906847","//doi.org/10.1016/S0091-6749(03)01888-8","//www.ncbi.nlm.nih.gov/pubmed/14564360","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3146358","//doi.org/10.1093/carcin/bgr044","//www.ncbi.nlm.nih.gov/pubmed/21393477","//www.ncbi.nlm.nih.gov/pubmed/10525065","//www.ncbi.nlm.nih.gov/pubmed/8683135","//doi.org/10.1016/0304-4165(94)90083-3","//www.ncbi.nlm.nih.gov/pubmed/7803484","//doi.org/10.1074/jbc.271.30.17821","//www.ncbi.nlm.nih.gov/pubmed/8663432","//www.ncbi.nlm.nih.gov/pubmed/8015286","//doi.org/10.1165/ajrcmb.21.1.3517","//www.ncbi.nlm.nih.gov/pubmed/10385597","http://www.commonchemistry.org/ChemicalDetail.aspx?ref=106154-18-1","https://chemapps.stolaf.edu/jmol/jmol.php?model=CCCCC%5CC%3DC/C%5CC%3DC/C%5CC%3DC/C%3DC/C(%3DO)CCCC(O)%3DO","https://www.ebi.ac.uk/chebi/searchId.do?chebiId=52449","https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL18028","http://www.chemspider.com/Chemical-Structure.4446283.html","http://www.kegg.jp/entry/C14732","https://pubchem.ncbi.nlm.nih.gov/compound/5283159"],"sections":[{"toclevel":1,"level":"2","line":"Biochemistry and production","number":"1","index":"1","fromtitle":"5-oxo-eicosatetraenoic_acid","byteoffset":2959,"anchor":"Biochemistry_and_production"},{"toclevel":1,"level":"2","line":"Tissue sources","number":"2","index":"2","fromtitle":"5-oxo-eicosatetraenoic_acid","byteoffset":7760,"anchor":"Tissue_sources"},{"toclevel":2,"level":"3","line":"Cellular production","number":"2.1","index":"3","fromtitle":"5-oxo-eicosatetraenoic_acid","byteoffset":7782,"anchor":"Cellular_production"},{"toclevel":2,"level":"3","line":"Transcellular production","number":"2.2","index":"4","fromtitle":"5-oxo-eicosatetraenoic_acid","byteoffset":8387,"anchor":"Transcellular_production"},{"toclevel":1,"level":"2","line":"Metabolism","number":"3","index":"5","fromtitle":"5-oxo-eicosatetraenoic_acid","byteoffset":10570,"anchor":"Metabolism"},{"toclevel":1,"level":"2","line":"Mechanism of action","number":"4","index":"6","fromtitle":"5-oxo-eicosatetraenoic_acid","byteoffset":14610,"anchor":"Mechanism_of_action"},{"toclevel":2,"level":"3","line":"The OXER1 receptor","number":"4.1","index":"7","fromtitle":"5-oxo-eicosatetraenoic_acid","byteoffset":14637,"anchor":"The_OXER1_receptor"},{"toclevel":2,"level":"3","line":"Other GPCR receptors","number":"4.2","index":"8","fromtitle":"5-oxo-eicosatetraenoic_acid","byteoffset":18073,"anchor":"Other_GPCR_receptors"},{"toclevel":2,"level":"3","line":"PPAR\u03b3","number":"4.3","index":"9","fromtitle":"5-oxo-eicosatetraenoic_acid","byteoffset":19001,"anchor":"PPAR\u03b3"},{"toclevel":2,"level":"3","line":"Other mechanisms","number":"4.4","index":"10","fromtitle":"5-oxo-eicosatetraenoic_acid","byteoffset":20487,"anchor":"Other_mechanisms"},{"toclevel":1,"level":"2","line":"Target cells","number":"5","index":"11","fromtitle":"5-oxo-eicosatetraenoic_acid","byteoffset":21056,"anchor":"Target_cells"},{"toclevel":2,"level":"3","line":"Inflammatory cells","number":"5.1","index":"12","fromtitle":"5-oxo-eicosatetraenoic_acid","byteoffset":21076,"anchor":"Inflammatory_cells"},{"toclevel":2,"level":"3","line":"Lung airway smooth muscle cells","number":"5.2","index":"13","fromtitle":"5-oxo-eicosatetraenoic_acid","byteoffset":23479,"anchor":"Lung_airway_smooth_muscle_cells"},{"toclevel":2,"level":"3","line":"Cancer cells","number":"5.3","index":"14","fromtitle":"5-oxo-eicosatetraenoic_acid","byteoffset":24383,"anchor":"Cancer_cells"},{"toclevel":2,"level":"3","line":"Steroidogenic cells","number":"5.4","index":"15","fromtitle":"5-oxo-eicosatetraenoic_acid","byteoffset":25301,"anchor":"Steroidogenic_cells"},{"toclevel":2,"level":"3","line":"Other cell types","number":"5.5","index":"16","fromtitle":"5-oxo-eicosatetraenoic_acid","byteoffset":25585,"anchor":"Other_cell_types"},{"toclevel":1,"level":"2","line":"Interaction with other stimuli","number":"6","index":"17","fromtitle":"5-oxo-eicosatetraenoic_acid","byteoffset":26080,"anchor":"Interaction_with_other_stimuli"},{"toclevel":1,"level":"2","line":"Clinical significance","number":"7","index":"18","fromtitle":"5-oxo-eicosatetraenoic_acid","byteoffset":29682,"anchor":"Clinical_significance"},{"toclevel":1,"level":"2","line":"See also","number":"8","index":"19","fromtitle":"5-oxo-eicosatetraenoic_acid","byteoffset":30378,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"References","number":"9","index":"20","fromtitle":"5-oxo-eicosatetraenoic_acid","byteoffset":30468,"anchor":"References"}],"parsewarnings":[],"displaytitle":"5-oxo-eicosatetraenoic acid","iwlinks":[],"properties":[{"name":"defaultsort","*":"5-oxo-ETE, 5-oxoETE, 5-oxoeicosatetraenoic acid"},{"name":"wikibase_item","*":"Q25323762"}]}}